date generated: 2023-08-29
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
x | |
---|---|
0610009B22Rik | 0.4565576 |
0610009E02Rik | -0.4069908 |
0610009L18Rik | -0.1869110 |
0610010K14Rik | -0.3711485 |
0610012G03Rik | -0.3421633 |
0610030E20Rik | 0.0842539 |
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 1604 |
num_genes_in_profile | 17643 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8424 |
num_profile_genes_not_in_sets | 9219 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used:
GMT file of genesets: mouse_msigdb_reactome_2022-02-16.gmtGene sets metrics | |
---|---|
num_genesets | 1604 |
num_genesets_excluded | 426 |
num_genesets_included | 1178 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Top N= 50 gene sets
## Warning in kable_styling(., "hover", full_width = FALSE): Please specify format
## in kable. kableExtra can customize either HTML or LaTeX outputs. See
## https://haozhu233.github.io/kableExtra/ for details.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
CITRIC ACID CYCLE TCA CYCLE | 22 | 3.44e-05 | 0.510 | 9.41e-04 |
OLFACTORY SIGNALING PATHWAY | 37 | 1.51e-07 | -0.499 | 1.11e-05 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 4.20e-03 | 0.498 | 3.30e-02 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 3.04e-03 | 0.494 | 2.58e-02 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 3.62e-03 | 0.485 | 2.96e-02 |
CALNEXIN CALRETICULIN CYCLE | 26 | 2.35e-05 | 0.479 | 7.68e-04 |
ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 1.58e-04 | 0.476 | 2.98e-03 |
RHOBTB3 ATPASE CYCLE | 10 | 9.36e-03 | 0.475 | 5.82e-02 |
BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 1.92e-04 | 0.470 | 3.37e-03 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 1.14e-03 | 0.470 | 1.27e-02 |
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 3.98e-03 | 0.461 | 3.17e-02 |
ASPARTATE AND ASPARAGINE METABOLISM | 10 | 1.25e-02 | 0.456 | 7.13e-02 |
MET ACTIVATES RAP1 AND RAC1 | 10 | 1.33e-02 | 0.452 | 7.32e-02 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 1.75e-04 | 0.452 | 3.21e-03 |
RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 4.82e-03 | 0.435 | 3.64e-02 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 1.87e-02 | 0.429 | 8.96e-02 |
SCAVENGING OF HEME FROM PLASMA | 11 | 1.44e-02 | -0.426 | 7.61e-02 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 9.82e-04 | 0.426 | 1.14e-02 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 1.56e-05 | 0.422 | 5.81e-04 |
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 27 | 1.88e-04 | 0.415 | 3.35e-03 |
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 3.13e-04 | 0.408 | 4.60e-03 |
CARNITINE METABOLISM | 14 | 8.34e-03 | 0.407 | 5.35e-02 |
ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | 10 | 2.60e-02 | 0.407 | 1.11e-01 |
HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | 10 | 2.60e-02 | 0.407 | 1.11e-01 |
PROLONGED ERK ACTIVATION EVENTS | 14 | 9.38e-03 | 0.401 | 5.82e-02 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 7.62e-03 | 0.398 | 5.04e-02 |
FERTILIZATION | 13 | 1.30e-02 | -0.398 | 7.27e-02 |
GLYCOSPHINGOLIPID METABOLISM | 38 | 2.63e-05 | 0.394 | 7.96e-04 |
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 3.83e-03 | 0.394 | 3.07e-02 |
SPHINGOLIPID METABOLISM | 80 | 1.27e-09 | 0.393 | 1.87e-07 |
DEFECTS OF CONTACT ACTIVATION SYSTEM CAS AND KALLIKREIN KININ SYSTEM KKS | 11 | 2.42e-02 | -0.392 | 1.07e-01 |
SPHINGOLIPID DE NOVO BIOSYNTHESIS | 42 | 1.25e-05 | 0.390 | 5.22e-04 |
NUCLEOBASE BIOSYNTHESIS | 15 | 1.00e-02 | 0.384 | 6.10e-02 |
COHESIN LOADING ONTO CHROMATIN | 10 | 3.74e-02 | 0.380 | 1.43e-01 |
CTLA4 INHIBITORY SIGNALING | 20 | 3.62e-03 | 0.376 | 2.96e-02 |
ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 1.98e-02 | 0.373 | 9.44e-02 |
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 1.24e-02 | 0.373 | 7.10e-02 |
RHOV GTPASE CYCLE | 33 | 2.41e-04 | 0.369 | 3.89e-03 |
PLATELET SENSITIZATION BY LDL | 15 | 1.38e-02 | 0.367 | 7.45e-02 |
INSULIN PROCESSING | 24 | 1.96e-03 | 0.365 | 1.88e-02 |
LDL CLEARANCE | 16 | 1.15e-02 | 0.365 | 6.71e-02 |
FATTY ACYL COA BIOSYNTHESIS | 32 | 4.06e-04 | 0.361 | 5.69e-03 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 4.93e-02 | 0.359 | 1.73e-01 |
RECEPTOR MEDIATED MITOPHAGY | 11 | 4.06e-02 | 0.357 | 1.52e-01 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 1.70e-02 | 0.356 | 8.53e-02 |
INTRA GOLGI TRAFFIC | 43 | 6.28e-05 | 0.353 | 1.45e-03 |
RHOF GTPASE CYCLE | 41 | 9.74e-05 | 0.352 | 2.05e-03 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 14 | 2.38e-02 | 0.349 | 1.07e-01 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 3.01e-02 | 0.347 | 1.22e-01 |
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 2.94e-05 | 0.345 | 8.65e-04 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
CITRIC ACID CYCLE TCA CYCLE | 22 | 3.44e-05 | 0.510000 | 9.41e-04 |
OLFACTORY SIGNALING PATHWAY | 37 | 1.51e-07 | -0.499000 | 1.11e-05 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 4.20e-03 | 0.498000 | 3.30e-02 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 3.04e-03 | 0.494000 | 2.58e-02 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 3.62e-03 | 0.485000 | 2.96e-02 |
CALNEXIN CALRETICULIN CYCLE | 26 | 2.35e-05 | 0.479000 | 7.68e-04 |
ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 1.58e-04 | 0.476000 | 2.98e-03 |
RHOBTB3 ATPASE CYCLE | 10 | 9.36e-03 | 0.475000 | 5.82e-02 |
BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 1.92e-04 | 0.470000 | 3.37e-03 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 1.14e-03 | 0.470000 | 1.27e-02 |
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 3.98e-03 | 0.461000 | 3.17e-02 |
ASPARTATE AND ASPARAGINE METABOLISM | 10 | 1.25e-02 | 0.456000 | 7.13e-02 |
MET ACTIVATES RAP1 AND RAC1 | 10 | 1.33e-02 | 0.452000 | 7.32e-02 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 1.75e-04 | 0.452000 | 3.21e-03 |
RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 4.82e-03 | 0.435000 | 3.64e-02 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 1.87e-02 | 0.429000 | 8.96e-02 |
SCAVENGING OF HEME FROM PLASMA | 11 | 1.44e-02 | -0.426000 | 7.61e-02 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 9.82e-04 | 0.426000 | 1.14e-02 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 1.56e-05 | 0.422000 | 5.81e-04 |
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 27 | 1.88e-04 | 0.415000 | 3.35e-03 |
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 3.13e-04 | 0.408000 | 4.60e-03 |
CARNITINE METABOLISM | 14 | 8.34e-03 | 0.407000 | 5.35e-02 |
ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | 10 | 2.60e-02 | 0.407000 | 1.11e-01 |
HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | 10 | 2.60e-02 | 0.407000 | 1.11e-01 |
PROLONGED ERK ACTIVATION EVENTS | 14 | 9.38e-03 | 0.401000 | 5.82e-02 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 7.62e-03 | 0.398000 | 5.04e-02 |
FERTILIZATION | 13 | 1.30e-02 | -0.398000 | 7.27e-02 |
GLYCOSPHINGOLIPID METABOLISM | 38 | 2.63e-05 | 0.394000 | 7.96e-04 |
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 3.83e-03 | 0.394000 | 3.07e-02 |
SPHINGOLIPID METABOLISM | 80 | 1.27e-09 | 0.393000 | 1.87e-07 |
DEFECTS OF CONTACT ACTIVATION SYSTEM CAS AND KALLIKREIN KININ SYSTEM KKS | 11 | 2.42e-02 | -0.392000 | 1.07e-01 |
SPHINGOLIPID DE NOVO BIOSYNTHESIS | 42 | 1.25e-05 | 0.390000 | 5.22e-04 |
NUCLEOBASE BIOSYNTHESIS | 15 | 1.00e-02 | 0.384000 | 6.10e-02 |
COHESIN LOADING ONTO CHROMATIN | 10 | 3.74e-02 | 0.380000 | 1.43e-01 |
CTLA4 INHIBITORY SIGNALING | 20 | 3.62e-03 | 0.376000 | 2.96e-02 |
ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 1.98e-02 | 0.373000 | 9.44e-02 |
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 1.24e-02 | 0.373000 | 7.10e-02 |
RHOV GTPASE CYCLE | 33 | 2.41e-04 | 0.369000 | 3.89e-03 |
PLATELET SENSITIZATION BY LDL | 15 | 1.38e-02 | 0.367000 | 7.45e-02 |
INSULIN PROCESSING | 24 | 1.96e-03 | 0.365000 | 1.88e-02 |
LDL CLEARANCE | 16 | 1.15e-02 | 0.365000 | 6.71e-02 |
FATTY ACYL COA BIOSYNTHESIS | 32 | 4.06e-04 | 0.361000 | 5.69e-03 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 4.93e-02 | 0.359000 | 1.73e-01 |
RECEPTOR MEDIATED MITOPHAGY | 11 | 4.06e-02 | 0.357000 | 1.52e-01 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 1.70e-02 | 0.356000 | 8.53e-02 |
INTRA GOLGI TRAFFIC | 43 | 6.28e-05 | 0.353000 | 1.45e-03 |
RHOF GTPASE CYCLE | 41 | 9.74e-05 | 0.352000 | 2.05e-03 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 14 | 2.38e-02 | 0.349000 | 1.07e-01 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 3.01e-02 | 0.347000 | 1.22e-01 |
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 2.94e-05 | 0.345000 | 8.65e-04 |
ACYL CHAIN REMODELLING OF PG | 10 | 5.97e-02 | 0.344000 | 1.94e-01 |
PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 2.23e-05 | 0.343000 | 7.51e-04 |
RHOU GTPASE CYCLE | 34 | 5.35e-04 | 0.343000 | 7.16e-03 |
WNT LIGAND BIOGENESIS AND TRAFFICKING | 21 | 6.55e-03 | 0.343000 | 4.52e-02 |
ACTIVATION OF THE TFAP2 AP 2 FAMILY OF TRANSCRIPTION FACTORS | 10 | 6.07e-02 | -0.343000 | 1.94e-01 |
RAP1 SIGNALLING | 15 | 2.28e-02 | 0.340000 | 1.04e-01 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 4.23e-02 | 0.339000 | 1.56e-01 |
CA DEPENDENT EVENTS | 36 | 4.51e-04 | 0.338000 | 6.25e-03 |
ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 15 | 2.42e-02 | 0.336000 | 1.07e-01 |
G PROTEIN MEDIATED EVENTS | 52 | 3.04e-05 | 0.334000 | 8.65e-04 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 18 | 1.48e-02 | 0.332000 | 7.70e-02 |
DNA METHYLATION | 23 | 6.01e-03 | -0.331000 | 4.26e-02 |
NCAM1 INTERACTIONS | 42 | 2.20e-04 | -0.330000 | 3.59e-03 |
CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 2.79e-02 | 0.328000 | 1.17e-01 |
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 2.88e-02 | 0.326000 | 1.19e-01 |
PEROXISOMAL LIPID METABOLISM | 27 | 3.49e-03 | 0.325000 | 2.89e-02 |
GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 4.26e-02 | 0.325000 | 1.56e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 15 | 3.04e-02 | 0.323000 | 1.23e-01 |
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 53 | 5.37e-05 | -0.321000 | 1.35e-03 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 1.58e-02 | 0.320000 | 8.00e-02 |
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 25 | 5.68e-03 | 0.320000 | 4.08e-02 |
SIGNALING BY HIPPO | 20 | 1.39e-02 | 0.318000 | 7.45e-02 |
ACTIVATION OF SMO | 16 | 2.85e-02 | 0.316000 | 1.19e-01 |
HYALURONAN UPTAKE AND DEGRADATION | 11 | 7.23e-02 | 0.313000 | 2.17e-01 |
E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 1.83e-02 | 0.313000 | 8.84e-02 |
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 24 | 8.35e-03 | -0.311000 | 5.35e-02 |
VEGFR2 MEDIATED VASCULAR PERMEABILITY | 27 | 5.32e-03 | 0.310000 | 3.91e-02 |
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 2.11e-04 | 0.309000 | 3.50e-03 |
RAF ACTIVATION | 34 | 1.85e-03 | 0.309000 | 1.82e-02 |
RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 1.05e-02 | -0.308000 | 6.30e-02 |
BIOTIN TRANSPORT AND METABOLISM | 11 | 7.69e-02 | 0.308000 | 2.22e-01 |
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 34 | 1.91e-03 | -0.308000 | 1.86e-02 |
IRE1ALPHA ACTIVATES CHAPERONES | 50 | 2.10e-04 | 0.303000 | 3.50e-03 |
EPHRIN SIGNALING | 19 | 2.26e-02 | 0.302000 | 1.03e-01 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 95 | 4.02e-07 | -0.301000 | 2.50e-05 |
ERKS ARE INACTIVATED | 13 | 6.07e-02 | 0.300000 | 1.94e-01 |
CONDENSATION OF PROPHASE CHROMOSOMES | 30 | 4.41e-03 | -0.300000 | 3.42e-02 |
O LINKED GLYCOSYLATION OF MUCINS | 41 | 9.25e-04 | 0.299000 | 1.09e-02 |
ELEVATION OF CYTOSOLIC CA2 LEVELS | 14 | 5.37e-02 | 0.298000 | 1.82e-01 |
INOSITOL PHOSPHATE METABOLISM | 46 | 5.03e-04 | 0.297000 | 6.81e-03 |
DEPOLYMERISATION OF THE NUCLEAR LAMINA | 13 | 6.45e-02 | 0.296000 | 2.01e-01 |
NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 32 | 3.81e-03 | 0.296000 | 3.07e-02 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 12 | 7.73e-02 | 0.295000 | 2.23e-01 |
COLLAGEN CHAIN TRIMERIZATION | 41 | 1.11e-03 | -0.294000 | 1.26e-02 |
EUKARYOTIC TRANSLATION ELONGATION | 87 | 2.12e-06 | -0.294000 | 1.19e-04 |
NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 21 | 2.05e-02 | 0.292000 | 9.76e-02 |
NEGATIVE REGULATION OF MET ACTIVITY | 20 | 2.38e-02 | 0.292000 | 1.07e-01 |
KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 4.40e-02 | -0.291000 | 1.60e-01 |
CD28 CO STIMULATION | 31 | 5.19e-03 | 0.290000 | 3.84e-02 |
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 14 | 6.04e-02 | 0.290000 | 1.94e-01 |
DEFECTS IN COBALAMIN B12 METABOLISM | 13 | 7.04e-02 | 0.290000 | 2.15e-01 |
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 26 | 1.09e-02 | 0.289000 | 6.41e-02 |
BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 4.69e-02 | 0.287000 | 1.67e-01 |
DAG AND IP3 SIGNALING | 40 | 1.71e-03 | 0.287000 | 1.75e-02 |
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 5.51e-02 | -0.286000 | 1.85e-01 |
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 1.05e-01 | -0.283000 | 2.74e-01 |
RHOB GTPASE CYCLE | 69 | 5.02e-05 | 0.282000 | 1.29e-03 |
TERMINATION OF O GLYCAN BIOSYNTHESIS | 10 | 1.23e-01 | 0.281000 | 3.05e-01 |
PI METABOLISM | 79 | 1.58e-05 | 0.281000 | 5.81e-04 |
DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 21 | 2.58e-02 | 0.281000 | 1.11e-01 |
GLYCOGEN METABOLISM | 25 | 1.54e-02 | 0.280000 | 7.89e-02 |
SYNTHESIS OF PA | 29 | 9.09e-03 | 0.280000 | 5.70e-02 |
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 1.35e-03 | 0.279000 | 1.43e-02 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 18 | 4.03e-02 | 0.279000 | 1.51e-01 |
COMPLEX I BIOGENESIS | 56 | 3.11e-04 | -0.279000 | 4.60e-03 |
PARASITE INFECTION | 54 | 4.04e-04 | 0.278000 | 5.69e-03 |
REGULATION OF IFNG SIGNALING | 13 | 8.40e-02 | 0.277000 | 2.35e-01 |
RHOG GTPASE CYCLE | 74 | 3.86e-05 | 0.277000 | 1.01e-03 |
REGULATION OF TP53 EXPRESSION AND DEGRADATION | 34 | 5.43e-03 | 0.276000 | 3.95e-02 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 14 | 7.46e-02 | 0.275000 | 2.19e-01 |
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 26 | 1.52e-02 | 0.275000 | 7.83e-02 |
NUCLEAR IMPORT OF REV PROTEIN | 32 | 7.24e-03 | 0.274000 | 4.90e-02 |
THE PHOTOTRANSDUCTION CASCADE | 22 | 2.63e-02 | -0.274000 | 1.12e-01 |
MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 3.01e-02 | 0.273000 | 1.22e-01 |
NUCLEAR ENVELOPE NE REASSEMBLY | 64 | 1.59e-04 | 0.273000 | 2.98e-03 |
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 14 | 7.87e-02 | 0.271000 | 2.26e-01 |
SUPPRESSION OF PHAGOSOMAL MATURATION | 12 | 1.04e-01 | 0.271000 | 2.74e-01 |
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 2.59e-02 | 0.268000 | 1.11e-01 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 8.33e-02 | 0.267000 | 2.34e-01 |
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 6.22e-03 | 0.267000 | 4.34e-02 |
GLYCOGEN SYNTHESIS | 14 | 8.54e-02 | 0.266000 | 2.38e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 15 | 7.51e-02 | 0.265000 | 2.19e-01 |
GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 30 | 1.20e-02 | 0.265000 | 6.90e-02 |
RHOJ GTPASE CYCLE | 55 | 6.83e-04 | 0.265000 | 8.65e-03 |
SPRY REGULATION OF FGF SIGNALING | 16 | 6.80e-02 | 0.264000 | 2.10e-01 |
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 5.30e-02 | 0.263000 | 1.81e-01 |
NEPHRIN FAMILY INTERACTIONS | 23 | 2.88e-02 | 0.263000 | 1.19e-01 |
CELLULAR HEXOSE TRANSPORT | 12 | 1.14e-01 | 0.263000 | 2.91e-01 |
AMINE LIGAND BINDING RECEPTORS | 29 | 1.46e-02 | 0.262000 | 7.64e-02 |
VLDLR INTERNALISATION AND DEGRADATION | 12 | 1.17e-01 | 0.261000 | 2.96e-01 |
GOLGI ASSOCIATED VESICLE BIOGENESIS | 55 | 8.05e-04 | 0.261000 | 9.68e-03 |
TRANS GOLGI NETWORK VESICLE BUDDING | 70 | 1.59e-04 | 0.261000 | 2.98e-03 |
DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 9.12e-02 | 0.261000 | 2.47e-01 |
VXPX CARGO TARGETING TO CILIUM | 19 | 4.93e-02 | 0.261000 | 1.73e-01 |
RNA POLYMERASE III CHAIN ELONGATION | 18 | 5.60e-02 | -0.260000 | 1.86e-01 |
LYSINE CATABOLISM | 11 | 1.35e-01 | 0.260000 | 3.25e-01 |
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 1.25e-02 | 0.259000 | 7.14e-02 |
ACTIVATION OF RAC1 | 13 | 1.07e-01 | 0.258000 | 2.77e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 14 | 9.44e-02 | 0.258000 | 2.53e-01 |
RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 7.36e-03 | 0.258000 | 4.95e-02 |
P75NTR REGULATES AXONOGENESIS | 10 | 1.60e-01 | 0.257000 | 3.59e-01 |
DISEASES OF DNA REPAIR | 11 | 1.40e-01 | 0.257000 | 3.33e-01 |
REGULATION OF GENE EXPRESSION BY HYPOXIA INDUCIBLE FACTOR | 10 | 1.60e-01 | 0.257000 | 3.59e-01 |
ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 1.60e-01 | 0.257000 | 3.59e-01 |
CD28 DEPENDENT VAV1 PATHWAY | 11 | 1.41e-01 | 0.256000 | 3.33e-01 |
PRE NOTCH PROCESSING IN GOLGI | 18 | 5.99e-02 | 0.256000 | 1.94e-01 |
ERK MAPK TARGETS | 22 | 3.79e-02 | 0.256000 | 1.45e-01 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 15 | 8.78e-02 | -0.255000 | 2.43e-01 |
PRC2 METHYLATES HISTONES AND DNA | 32 | 1.28e-02 | -0.254000 | 7.26e-02 |
SCAVENGING BY CLASS A RECEPTORS | 14 | 9.96e-02 | -0.254000 | 2.65e-01 |
ACYL CHAIN REMODELLING OF PE | 18 | 6.21e-02 | 0.254000 | 1.97e-01 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 1.28e-01 | 0.254000 | 3.12e-01 |
NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 7.55e-03 | 0.254000 | 5.02e-02 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 3.96e-02 | 0.253000 | 1.50e-01 |
PHOSPHOLIPID METABOLISM | 187 | 2.54e-09 | 0.253000 | 3.00e-07 |
RESPONSE OF MTB TO PHAGOCYTOSIS | 21 | 4.57e-02 | 0.252000 | 1.64e-01 |
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 1.73e-03 | 0.251000 | 1.75e-02 |
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 20 | 5.21e-02 | 0.251000 | 1.80e-01 |
APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 1.71e-01 | -0.250000 | 3.73e-01 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 1.51e-01 | -0.250000 | 3.48e-01 |
DERMATAN SULFATE BIOSYNTHESIS | 11 | 1.52e-01 | 0.249000 | 3.49e-01 |
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 2.26e-02 | 0.249000 | 1.03e-01 |
MTOR SIGNALLING | 40 | 6.56e-03 | 0.248000 | 4.52e-02 |
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 1.75e-01 | 0.248000 | 3.79e-01 |
SYNTHESIS OF PE | 13 | 1.22e-01 | 0.247000 | 3.04e-01 |
DEADENYLATION OF MRNA | 25 | 3.32e-02 | 0.246000 | 1.31e-01 |
MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 2.18e-02 | 0.246000 | 1.02e-01 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 1.25e-01 | -0.246000 | 3.07e-01 |
CHONDROITIN SULFATE BIOSYNTHESIS | 18 | 7.15e-02 | 0.245000 | 2.17e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 1.26e-01 | 0.245000 | 3.09e-01 |
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 84 | 1.13e-04 | 0.244000 | 2.26e-03 |
RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 88 | 7.85e-05 | 0.244000 | 1.68e-03 |
GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 1.62e-01 | 0.243000 | 3.60e-01 |
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 1.45e-02 | 0.242000 | 7.62e-02 |
NONSENSE MEDIATED DECAY NMD | 109 | 1.29e-05 | -0.242000 | 5.22e-04 |
TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | 10 | 1.85e-01 | -0.242000 | 3.92e-01 |
KILLING MECHANISMS | 11 | 1.66e-01 | -0.241000 | 3.66e-01 |
CD28 DEPENDENT PI3K AKT SIGNALING | 21 | 5.56e-02 | 0.241000 | 1.86e-01 |
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 28 | 2.72e-02 | 0.241000 | 1.14e-01 |
NRAGE SIGNALS DEATH THROUGH JNK | 56 | 1.81e-03 | 0.241000 | 1.79e-02 |
TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 1.33e-01 | 0.241000 | 3.21e-01 |
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 81 | 1.83e-04 | 0.241000 | 3.32e-03 |
TRIGLYCERIDE BIOSYNTHESIS | 10 | 1.88e-01 | 0.240000 | 3.97e-01 |
RAC2 GTPASE CYCLE | 88 | 9.92e-05 | 0.240000 | 2.05e-03 |
RND2 GTPASE CYCLE | 39 | 9.68e-03 | 0.239000 | 5.91e-02 |
MITOTIC TELOPHASE CYTOKINESIS | 13 | 1.35e-01 | 0.239000 | 3.25e-01 |
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 27 | 3.17e-02 | -0.239000 | 1.28e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS | 23 | 4.80e-02 | 0.238000 | 1.70e-01 |
SIGNALING BY WNT IN CANCER | 31 | 2.20e-02 | 0.238000 | 1.02e-01 |
DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 9.09e-02 | 0.237000 | 2.47e-01 |
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 24 | 4.51e-02 | 0.236000 | 1.62e-01 |
COPI MEDIATED ANTEROGRADE TRANSPORT | 91 | 1.03e-04 | 0.236000 | 2.09e-03 |
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 2.33e-02 | 0.235000 | 1.06e-01 |
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 25 | 4.17e-02 | -0.235000 | 1.55e-01 |
RHOC GTPASE CYCLE | 74 | 4.73e-04 | 0.235000 | 6.48e-03 |
TBC RABGAPS | 43 | 7.69e-03 | 0.235000 | 5.06e-02 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 1.29e-01 | 0.235000 | 3.13e-01 |
UNWINDING OF DNA | 12 | 1.61e-01 | 0.234000 | 3.60e-01 |
FORMATION OF THE CORNIFIED ENVELOPE | 31 | 2.42e-02 | -0.234000 | 1.07e-01 |
GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 109 | 2.63e-05 | 0.233000 | 7.96e-04 |
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 2.99e-02 | 0.233000 | 1.22e-01 |
PEROXISOMAL PROTEIN IMPORT | 59 | 2.07e-03 | 0.232000 | 1.95e-02 |
CYTOSOLIC TRNA AMINOACYLATION | 24 | 4.94e-02 | 0.232000 | 1.73e-01 |
RESOLUTION OF SISTER CHROMATID COHESION | 102 | 5.49e-05 | 0.231000 | 1.35e-03 |
INHIBITION OF DNA RECOMBINATION AT TELOMERE | 38 | 1.37e-02 | -0.231000 | 7.45e-02 |
SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 2.21e-02 | 0.230000 | 1.02e-01 |
MEMBRANE TRAFFICKING | 581 | 3.96e-21 | 0.230000 | 4.66e-18 |
TRNA AMINOACYLATION | 42 | 1.02e-02 | 0.229000 | 6.13e-02 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 6.43e-05 | -0.229000 | 1.46e-03 |
ASPARAGINE N LINKED GLYCOSYLATION | 285 | 3.17e-11 | 0.229000 | 6.23e-09 |
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 2.11e-01 | 0.228000 | 4.31e-01 |
RHOQ GTPASE CYCLE | 58 | 2.65e-03 | 0.228000 | 2.35e-02 |
PYRUVATE METABOLISM | 27 | 4.03e-02 | 0.228000 | 1.51e-01 |
CLATHRIN MEDIATED ENDOCYTOSIS | 133 | 6.12e-06 | 0.227000 | 3.00e-04 |
LYSOSOME VESICLE BIOGENESIS | 33 | 2.40e-02 | 0.227000 | 1.07e-01 |
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 13 | 1.57e-01 | 0.227000 | 3.56e-01 |
HEME BIOSYNTHESIS | 13 | 1.57e-01 | 0.227000 | 3.56e-01 |
OPIOID SIGNALLING | 87 | 2.60e-04 | 0.227000 | 4.04e-03 |
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 2.23e-02 | 0.226000 | 1.03e-01 |
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 38 | 1.58e-02 | 0.226000 | 8.00e-02 |
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 185 | 1.18e-07 | 0.226000 | 9.96e-06 |
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 16 | 1.19e-01 | 0.225000 | 2.98e-01 |
G0 AND EARLY G1 | 25 | 5.11e-02 | 0.225000 | 1.77e-01 |
G1 S SPECIFIC TRANSCRIPTION | 26 | 4.69e-02 | 0.225000 | 1.67e-01 |
REGULATION OF KIT SIGNALING | 16 | 1.19e-01 | 0.225000 | 2.98e-01 |
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 171 | 3.92e-07 | 0.225000 | 2.50e-05 |
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 85 | 3.38e-04 | 0.225000 | 4.92e-03 |
UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 1.97e-01 | 0.225000 | 4.07e-01 |
RMTS METHYLATE HISTONE ARGININES | 46 | 8.40e-03 | -0.225000 | 5.35e-02 |
GLYCOGEN STORAGE DISEASES | 12 | 1.78e-01 | 0.225000 | 3.83e-01 |
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 8.24e-02 | 0.224000 | 2.32e-01 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 2.21e-01 | 0.224000 | 4.41e-01 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 1.01e-01 | -0.223000 | 2.69e-01 |
MTORC1 MEDIATED SIGNALLING | 24 | 5.92e-02 | 0.222000 | 1.93e-01 |
PECAM1 INTERACTIONS | 12 | 1.82e-01 | 0.222000 | 3.88e-01 |
RAB REGULATION OF TRAFFICKING | 119 | 3.08e-05 | 0.221000 | 8.65e-04 |
BLOOD GROUP SYSTEMS BIOSYNTHESIS | 15 | 1.39e-01 | 0.221000 | 3.31e-01 |
GAP JUNCTION DEGRADATION | 11 | 2.06e-01 | 0.220000 | 4.21e-01 |
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 24 | 6.20e-02 | 0.220000 | 1.97e-01 |
RHOD GTPASE CYCLE | 51 | 6.63e-03 | 0.220000 | 4.54e-02 |
NUCLEAR ENVELOPE BREAKDOWN | 49 | 7.94e-03 | 0.219000 | 5.17e-02 |
SIGNALLING TO ERKS | 34 | 2.70e-02 | 0.219000 | 1.14e-01 |
REGULATION OF SIGNALING BY CBL | 22 | 7.58e-02 | 0.219000 | 2.20e-01 |
SUMOYLATION OF DNA REPLICATION PROTEINS | 43 | 1.32e-02 | 0.218000 | 7.32e-02 |
PIWI INTERACTING RNA PIRNA BIOGENESIS | 19 | 9.97e-02 | -0.218000 | 2.65e-01 |
TIGHT JUNCTION INTERACTIONS | 16 | 1.31e-01 | 0.218000 | 3.18e-01 |
TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 1.92e-01 | 0.218000 | 4.01e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 15 | 1.45e-01 | 0.218000 | 3.39e-01 |
PLATELET CALCIUM HOMEOSTASIS | 26 | 5.58e-02 | 0.217000 | 1.86e-01 |
FGFR2 LIGAND BINDING AND ACTIVATION | 12 | 1.94e-01 | -0.217000 | 4.03e-01 |
ER TO GOLGI ANTEROGRADE TRANSPORT | 142 | 8.59e-06 | 0.216000 | 3.75e-04 |
HIV ELONGATION ARREST AND RECOVERY | 32 | 3.43e-02 | -0.216000 | 1.34e-01 |
RHOA GTPASE CYCLE | 143 | 8.44e-06 | 0.216000 | 3.75e-04 |
GLYCOSAMINOGLYCAN METABOLISM | 113 | 7.73e-05 | 0.215000 | 1.68e-03 |
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 24 | 6.82e-02 | 0.215000 | 2.10e-01 |
FCGR3A MEDIATED IL10 SYNTHESIS | 32 | 3.53e-02 | 0.215000 | 1.37e-01 |
METABOLISM OF COFACTORS | 19 | 1.05e-01 | -0.215000 | 2.74e-01 |
BILE ACID AND BILE SALT METABOLISM | 26 | 5.82e-02 | 0.215000 | 1.91e-01 |
PLATELET ADHESION TO EXPOSED COLLAGEN | 13 | 1.80e-01 | -0.215000 | 3.85e-01 |
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 1.75e-02 | 0.214000 | 8.63e-02 |
NEGATIVE REGULATION OF FGFR3 SIGNALING | 24 | 6.91e-02 | 0.214000 | 2.12e-01 |
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 75 | 1.34e-03 | 0.214000 | 1.43e-02 |
GABA RECEPTOR ACTIVATION | 55 | 6.04e-03 | 0.214000 | 4.26e-02 |
SLC TRANSPORTER DISORDERS | 76 | 1.27e-03 | 0.214000 | 1.40e-02 |
GOLGI TO ER RETROGRADE TRANSPORT | 119 | 5.70e-05 | 0.214000 | 1.37e-03 |
RHOBTB1 GTPASE CYCLE | 23 | 7.70e-02 | 0.213000 | 2.22e-01 |
ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 36 | 2.70e-02 | 0.213000 | 1.14e-01 |
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 2.02e-01 | 0.213000 | 4.17e-01 |
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 102 | 2.10e-04 | 0.212000 | 3.50e-03 |
KERATINIZATION | 32 | 3.82e-02 | -0.212000 | 1.46e-01 |
MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 21 | 9.31e-02 | 0.212000 | 2.50e-01 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 2.25e-01 | 0.211000 | 4.48e-01 |
SARS COV 2 INFECTION | 65 | 3.35e-03 | 0.210000 | 2.82e-02 |
HDACS DEACETYLATE HISTONES | 49 | 1.09e-02 | -0.210000 | 6.41e-02 |
DARPP 32 EVENTS | 23 | 8.09e-02 | 0.210000 | 2.29e-01 |
PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 1.13e-01 | 0.210000 | 2.89e-01 |
B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 50 | 1.02e-02 | -0.210000 | 6.13e-02 |
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 49 | 1.11e-02 | 0.210000 | 6.51e-02 |
PLASMA LIPOPROTEIN CLEARANCE | 28 | 5.50e-02 | 0.210000 | 1.85e-01 |
BUDDING AND MATURATION OF HIV VIRION | 27 | 5.97e-02 | 0.209000 | 1.94e-01 |
RND1 GTPASE CYCLE | 38 | 2.56e-02 | 0.209000 | 1.11e-01 |
INTERLEUKIN 17 SIGNALING | 68 | 2.90e-03 | 0.209000 | 2.48e-02 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 2.31e-01 | 0.208000 | 4.53e-01 |
GPVI MEDIATED ACTIVATION CASCADE | 31 | 4.48e-02 | 0.208000 | 1.62e-01 |
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 182 | 1.33e-06 | 0.208000 | 7.81e-05 |
BASE EXCISION REPAIR AP SITE FORMATION | 32 | 4.22e-02 | -0.207000 | 1.56e-01 |
TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 2.15e-01 | 0.207000 | 4.34e-01 |
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 1.02e-01 | 0.206000 | 2.69e-01 |
SIGNALING BY BMP | 25 | 7.48e-02 | 0.206000 | 2.19e-01 |
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 1.03e-01 | 0.206000 | 2.71e-01 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 2.61e-04 | -0.205000 | 4.04e-03 |
TRANSMISSION ACROSS CHEMICAL SYNAPSES | 244 | 3.73e-08 | 0.205000 | 3.66e-06 |
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 1.57e-01 | -0.204000 | 3.56e-01 |
FATTY ACID METABOLISM | 147 | 2.16e-05 | 0.203000 | 7.50e-04 |
VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 1.26e-01 | 0.203000 | 3.09e-01 |
INTEGRIN SIGNALING | 24 | 8.56e-02 | 0.203000 | 2.38e-01 |
SARS COV 1 INFECTION | 48 | 1.55e-02 | 0.202000 | 7.92e-02 |
VESICLE MEDIATED TRANSPORT | 613 | 1.95e-17 | 0.201000 | 7.67e-15 |
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 1.63e-01 | 0.201000 | 3.62e-01 |
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 1.65e-01 | 0.201000 | 3.64e-01 |
KERATAN SULFATE BIOSYNTHESIS | 24 | 8.89e-02 | 0.201000 | 2.45e-01 |
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 5.81e-02 | 0.200000 | 1.91e-01 |
METABOLISM OF CARBOHYDRATES | 260 | 3.05e-08 | 0.200000 | 3.27e-06 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 1.17e-04 | -0.200000 | 2.30e-03 |
EPHB MEDIATED FORWARD SIGNALING | 42 | 2.53e-02 | 0.200000 | 1.10e-01 |
PENTOSE PHOSPHATE PATHWAY | 13 | 2.13e-01 | 0.199000 | 4.33e-01 |
SIGNALING BY NTRK2 TRKB | 24 | 9.09e-02 | 0.199000 | 2.47e-01 |
AUTOPHAGY | 138 | 5.92e-05 | 0.198000 | 1.39e-03 |
MISMATCH REPAIR | 15 | 1.84e-01 | 0.198000 | 3.91e-01 |
MITOTIC SPINDLE CHECKPOINT | 97 | 7.52e-04 | 0.198000 | 9.23e-03 |
METABOLISM OF LIPIDS | 618 | 5.42e-17 | 0.198000 | 1.60e-14 |
PURINE SALVAGE | 12 | 2.36e-01 | 0.198000 | 4.56e-01 |
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 33 | 4.98e-02 | 0.197000 | 1.74e-01 |
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 2.02e-01 | 0.197000 | 4.17e-01 |
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 49 | 1.72e-02 | -0.197000 | 8.56e-02 |
KERATAN SULFATE KERATIN METABOLISM | 30 | 6.28e-02 | 0.196000 | 1.97e-01 |
COPII MEDIATED VESICLE TRANSPORT | 66 | 5.84e-03 | 0.196000 | 4.17e-02 |
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 17 | 1.62e-01 | 0.196000 | 3.60e-01 |
VITAMIN B5 PANTOTHENATE METABOLISM | 15 | 1.90e-01 | 0.196000 | 3.99e-01 |
NEUROTRANSMITTER RELEASE CYCLE | 49 | 1.79e-02 | 0.196000 | 8.75e-02 |
ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 35 | 4.54e-02 | -0.196000 | 1.63e-01 |
LGI ADAM INTERACTIONS | 14 | 2.05e-01 | -0.195000 | 4.21e-01 |
NETRIN 1 SIGNALING | 50 | 1.71e-02 | 0.195000 | 8.53e-02 |
INTERLEUKIN 6 SIGNALING | 10 | 2.87e-01 | 0.195000 | 5.21e-01 |
GABA B RECEPTOR ACTIVATION | 40 | 3.35e-02 | 0.194000 | 1.32e-01 |
FCERI MEDIATED MAPK ACTIVATION | 28 | 7.56e-02 | 0.194000 | 2.20e-01 |
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 2.66e-01 | 0.194000 | 4.97e-01 |
RECYCLING PATHWAY OF L1 | 40 | 3.44e-02 | 0.193000 | 1.34e-01 |
METABOLISM OF PORPHYRINS | 19 | 1.45e-01 | 0.193000 | 3.39e-01 |
DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 7.20e-02 | 0.193000 | 2.17e-01 |
INTERLEUKIN 37 SIGNALING | 18 | 1.57e-01 | 0.193000 | 3.56e-01 |
INTEGRATION OF ENERGY METABOLISM | 100 | 8.88e-04 | 0.192000 | 1.06e-02 |
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 48 | 2.14e-02 | 0.192000 | 1.01e-01 |
MEIOTIC RECOMBINATION | 41 | 3.43e-02 | -0.191000 | 1.34e-01 |
PEPTIDE HORMONE METABOLISM | 62 | 9.44e-03 | 0.191000 | 5.82e-02 |
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 26 | 9.26e-02 | 0.191000 | 2.50e-01 |
RND3 GTPASE CYCLE | 38 | 4.26e-02 | 0.190000 | 1.56e-01 |
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 1.39e-02 | 0.190000 | 7.45e-02 |
FORMATION OF APOPTOSOME | 10 | 2.99e-01 | 0.190000 | 5.34e-01 |
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 91 | 1.78e-03 | 0.190000 | 1.78e-02 |
HS GAG BIOSYNTHESIS | 30 | 7.27e-02 | 0.189000 | 2.17e-01 |
COSTIMULATION BY THE CD28 FAMILY | 50 | 2.08e-02 | 0.189000 | 9.86e-02 |
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 3.04e-01 | 0.188000 | 5.39e-01 |
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 3.04e-01 | 0.188000 | 5.39e-01 |
EUKARYOTIC TRANSLATION INITIATION | 114 | 5.52e-04 | -0.187000 | 7.30e-03 |
UNFOLDED PROTEIN RESPONSE UPR | 86 | 2.80e-03 | 0.187000 | 2.41e-02 |
EFFECTS OF PIP2 HYDROLYSIS | 27 | 9.59e-02 | 0.185000 | 2.57e-01 |
SIGNALING BY NTRKS | 130 | 2.76e-04 | 0.185000 | 4.17e-03 |
NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 97 | 1.73e-03 | 0.184000 | 1.75e-02 |
CIRCADIAN CLOCK | 68 | 8.67e-03 | 0.184000 | 5.49e-02 |
RAC3 GTPASE CYCLE | 91 | 2.42e-03 | 0.184000 | 2.23e-02 |
G ALPHA 12 13 SIGNALLING EVENTS | 76 | 5.58e-03 | 0.184000 | 4.03e-02 |
PROCESSING AND ACTIVATION OF SUMO | 10 | 3.16e-01 | 0.183000 | 5.52e-01 |
INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 2.21e-01 | 0.183000 | 4.41e-01 |
TRNA PROCESSING IN THE NUCLEUS | 56 | 1.83e-02 | 0.182000 | 8.84e-02 |
TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 91 | 2.71e-03 | 0.182000 | 2.36e-02 |
SIALIC ACID METABOLISM | 32 | 7.49e-02 | 0.182000 | 2.19e-01 |
PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 12 | 2.75e-01 | -0.182000 | 5.07e-01 |
SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 5.60e-02 | 0.182000 | 1.86e-01 |
CELLULAR RESPONSE TO HEAT STRESS | 94 | 2.51e-03 | 0.180000 | 2.25e-02 |
MHC CLASS II ANTIGEN PRESENTATION | 102 | 1.67e-03 | 0.180000 | 1.72e-02 |
SLC MEDIATED TRANSMEMBRANE TRANSPORT | 193 | 1.63e-05 | 0.180000 | 5.81e-04 |
RHO GTPASES ACTIVATE KTN1 | 11 | 3.01e-01 | 0.180000 | 5.36e-01 |
MYD88 INDEPENDENT TLR4 CASCADE | 93 | 2.75e-03 | 0.180000 | 2.38e-02 |
HDR THROUGH MMEJ ALT NHEJ | 10 | 3.25e-01 | 0.180000 | 5.64e-01 |
SYNTHESIS OF PC | 26 | 1.14e-01 | 0.179000 | 2.91e-01 |
RHO GTPASES ACTIVATE FORMINS | 119 | 7.50e-04 | 0.179000 | 9.23e-03 |
ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 3.28e-01 | 0.179000 | 5.67e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 9.06e-02 | 0.179000 | 2.47e-01 |
SIGNALING BY RETINOIC ACID | 33 | 7.64e-02 | 0.178000 | 2.22e-01 |
RAC1 GTPASE CYCLE | 180 | 3.81e-05 | 0.178000 | 1.01e-03 |
FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 3.30e-01 | 0.178000 | 5.68e-01 |
BASIGIN INTERACTIONS | 22 | 1.48e-01 | 0.178000 | 3.42e-01 |
SIGNALING BY ACTIVIN | 12 | 2.86e-01 | 0.178000 | 5.20e-01 |
TNF SIGNALING | 43 | 4.42e-02 | 0.177000 | 1.60e-01 |
INTEGRIN CELL SURFACE INTERACTIONS | 75 | 7.94e-03 | -0.177000 | 5.17e-02 |
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 35 | 7.00e-02 | -0.177000 | 2.14e-01 |
DNA STRAND ELONGATION | 32 | 8.34e-02 | 0.177000 | 2.34e-01 |
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 2.70e-01 | 0.177000 | 5.02e-01 |
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 1.53e-01 | 0.176000 | 3.50e-01 |
GP1B IX V ACTIVATION SIGNALLING | 11 | 3.12e-01 | -0.176000 | 5.49e-01 |
CS DS DEGRADATION | 14 | 2.57e-01 | 0.175000 | 4.85e-01 |
FGFR2 MUTANT RECEPTOR ACTIVATION | 27 | 1.16e-01 | -0.175000 | 2.95e-01 |
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 1.47e-01 | -0.175000 | 3.40e-01 |
PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 2.28e-01 | 0.174000 | 4.51e-01 |
GLUCONEOGENESIS | 27 | 1.18e-01 | 0.174000 | 2.98e-01 |
SUMOYLATION OF RNA BINDING PROTEINS | 45 | 4.39e-02 | 0.174000 | 1.60e-01 |
SIGNALING BY HEDGEHOG | 141 | 3.75e-04 | 0.174000 | 5.39e-03 |
SIGNALING BY VEGF | 104 | 2.26e-03 | 0.173000 | 2.09e-02 |
RHO GTPASE CYCLE | 425 | 9.79e-10 | 0.173000 | 1.65e-07 |
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 22 | 1.60e-01 | 0.173000 | 3.59e-01 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 2.18e-01 | -0.173000 | 4.38e-01 |
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 47 | 4.09e-02 | -0.172000 | 1.53e-01 |
PLATELET ACTIVATION SIGNALING AND AGGREGATION | 225 | 8.54e-06 | 0.172000 | 3.75e-04 |
TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 63 | 1.80e-02 | 0.172000 | 8.78e-02 |
RAB GERANYLGERANYLATION | 57 | 2.48e-02 | 0.172000 | 1.09e-01 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 1.66e-02 | -0.172000 | 8.35e-02 |
SIGNALING BY SCF KIT | 41 | 5.73e-02 | 0.172000 | 1.89e-01 |
IRON UPTAKE AND TRANSPORT | 52 | 3.24e-02 | 0.172000 | 1.29e-01 |
ERYTHROPOIETIN ACTIVATES RAS | 13 | 2.85e-01 | 0.171000 | 5.19e-01 |
COLLAGEN DEGRADATION | 52 | 3.26e-02 | -0.171000 | 1.29e-01 |
SIGNALING BY MET | 74 | 1.09e-02 | 0.171000 | 6.41e-02 |
TRIGLYCERIDE METABOLISM | 24 | 1.46e-01 | 0.171000 | 3.40e-01 |
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 93 | 4.72e-03 | 0.170000 | 3.59e-02 |
CELL CELL COMMUNICATION | 106 | 2.66e-03 | 0.169000 | 2.35e-02 |
INTERLEUKIN 10 SIGNALING | 20 | 1.91e-01 | -0.169000 | 4.01e-01 |
RNA POLYMERASE I PROMOTER ESCAPE | 50 | 3.91e-02 | -0.169000 | 1.48e-01 |
G ALPHA Z SIGNALLING EVENTS | 44 | 5.30e-02 | 0.169000 | 1.81e-01 |
GLUCOSE METABOLISM | 81 | 8.84e-03 | 0.168000 | 5.57e-02 |
FGFR1 MUTANT RECEPTOR ACTIVATION | 26 | 1.37e-01 | 0.168000 | 3.29e-01 |
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 86 | 7.13e-03 | 0.168000 | 4.85e-02 |
P75 NTR RECEPTOR MEDIATED SIGNALLING | 95 | 4.73e-03 | 0.168000 | 3.59e-02 |
SHC MEDIATED CASCADE FGFR4 | 13 | 2.96e-01 | -0.167000 | 5.32e-01 |
CARGO CONCENTRATION IN THE ER | 31 | 1.07e-01 | 0.167000 | 2.77e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 2.64e-01 | 0.167000 | 4.94e-01 |
AMINO ACIDS REGULATE MTORC1 | 51 | 3.96e-02 | 0.167000 | 1.50e-01 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 162 | 2.73e-04 | -0.166000 | 4.17e-03 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 1.30e-01 | -0.165000 | 3.16e-01 |
PROTEIN METHYLATION | 17 | 2.40e-01 | 0.165000 | 4.61e-01 |
DEATH RECEPTOR SIGNALLING | 134 | 1.01e-03 | 0.165000 | 1.16e-02 |
METABOLISM OF STEROIDS | 116 | 2.23e-03 | 0.164000 | 2.08e-02 |
SIGNALING BY EGFR | 47 | 5.28e-02 | 0.163000 | 1.81e-01 |
SIGNAL AMPLIFICATION | 31 | 1.16e-01 | 0.163000 | 2.95e-01 |
SELENOAMINO ACID METABOLISM | 108 | 3.48e-03 | -0.163000 | 2.89e-02 |
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 52 | 4.24e-02 | -0.163000 | 1.56e-01 |
ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 30 | 1.24e-01 | 0.162000 | 3.05e-01 |
MUCOPOLYSACCHARIDOSES | 11 | 3.53e-01 | 0.162000 | 5.89e-01 |
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 65 | 2.44e-02 | -0.162000 | 1.07e-01 |
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 1.50e-02 | 0.161000 | 7.79e-02 |
SULFUR AMINO ACID METABOLISM | 23 | 1.80e-01 | 0.161000 | 3.85e-01 |
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 14 | 2.97e-01 | 0.161000 | 5.32e-01 |
HYALURONAN METABOLISM | 15 | 2.80e-01 | 0.161000 | 5.13e-01 |
MITOCHONDRIAL TRANSLATION | 93 | 7.48e-03 | -0.161000 | 5.01e-02 |
MITOTIC METAPHASE AND ANAPHASE | 207 | 7.19e-05 | 0.160000 | 1.60e-03 |
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 74 | 1.74e-02 | 0.160000 | 8.63e-02 |
SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 2.69e-01 | 0.160000 | 5.01e-01 |
IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 3.60e-01 | -0.160000 | 5.96e-01 |
REGULATION OF TNFR1 SIGNALING | 34 | 1.08e-01 | 0.159000 | 2.78e-01 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 63 | 2.90e-02 | -0.159000 | 1.19e-01 |
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 2.71e-01 | -0.159000 | 5.02e-01 |
CYCLIN D ASSOCIATED EVENTS IN G1 | 46 | 6.20e-02 | 0.159000 | 1.97e-01 |
SENSORY PERCEPTION | 158 | 6.00e-04 | -0.158000 | 7.77e-03 |
EGFR DOWNREGULATION | 28 | 1.47e-01 | 0.158000 | 3.40e-01 |
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 12 | 3.45e-01 | 0.158000 | 5.80e-01 |
RHOBTB2 GTPASE CYCLE | 23 | 1.93e-01 | 0.157000 | 4.03e-01 |
CDC42 GTPASE CYCLE | 155 | 7.64e-04 | 0.157000 | 9.28e-03 |
REGULATION OF INSULIN SECRETION | 72 | 2.16e-02 | 0.157000 | 1.01e-01 |
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 631 | 2.39e-11 | 0.156000 | 5.62e-09 |
TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 1.46e-01 | 0.156000 | 3.39e-01 |
NEURONAL SYSTEM | 371 | 2.57e-07 | 0.156000 | 1.78e-05 |
PROTEIN UBIQUITINATION | 70 | 2.42e-02 | 0.156000 | 1.07e-01 |
ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 2.40e-01 | 0.156000 | 4.61e-01 |
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 3.31e-01 | -0.156000 | 5.68e-01 |
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 3.71e-01 | 0.156000 | 6.08e-01 |
CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 2.54e-01 | 0.155000 | 4.79e-01 |
DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 33 | 1.23e-01 | -0.155000 | 3.05e-01 |
POST TRANSLATIONAL PROTEIN MODIFICATION | 1226 | 1.18e-19 | 0.155000 | 6.97e-17 |
RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 2.33e-01 | 0.154000 | 4.54e-01 |
INSULIN RECEPTOR RECYCLING | 20 | 2.35e-01 | 0.154000 | 4.55e-01 |
LONG TERM POTENTIATION | 23 | 2.03e-01 | 0.153000 | 4.17e-01 |
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 107 | 6.14e-03 | 0.153000 | 4.31e-02 |
PI 3K CASCADE FGFR3 | 13 | 3.39e-01 | 0.153000 | 5.75e-01 |
HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 52 | 5.68e-02 | 0.153000 | 1.88e-01 |
NUCLEOBASE CATABOLISM | 31 | 1.42e-01 | 0.152000 | 3.35e-01 |
RHO GTPASES ACTIVATE PKNS | 50 | 6.28e-02 | -0.152000 | 1.97e-01 |
SIGNALING BY KIT IN DISEASE | 20 | 2.40e-01 | 0.152000 | 4.61e-01 |
DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 146 | 1.60e-03 | 0.151000 | 1.68e-02 |
INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 2.43e-01 | 0.151000 | 4.64e-01 |
SIGNAL TRANSDUCTION BY L1 | 21 | 2.33e-01 | 0.150000 | 4.54e-01 |
HOST INTERACTIONS OF HIV FACTORS | 125 | 3.70e-03 | 0.150000 | 3.01e-02 |
PROTEIN LOCALIZATION | 158 | 1.14e-03 | 0.150000 | 1.27e-02 |
MET PROMOTES CELL MOTILITY | 39 | 1.05e-01 | 0.150000 | 2.74e-01 |
CD209 DC SIGN SIGNALING | 18 | 2.71e-01 | 0.150000 | 5.02e-01 |
TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 8.76e-02 | 0.149000 | 2.43e-01 |
G ALPHA I SIGNALLING EVENTS | 204 | 2.52e-04 | 0.149000 | 4.02e-03 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 1.67e-01 | 0.148000 | 3.67e-01 |
METABOLISM OF NUCLEOTIDES | 92 | 1.43e-02 | 0.148000 | 7.59e-02 |
TRANSCRIPTIONAL REGULATION BY RUNX1 | 182 | 5.89e-04 | -0.148000 | 7.71e-03 |
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 119 | 5.38e-03 | 0.148000 | 3.94e-02 |
MYOGENESIS | 25 | 2.01e-01 | 0.148000 | 4.16e-01 |
SEROTONIN RECEPTORS | 10 | 4.19e-01 | 0.148000 | 6.48e-01 |
REGULATION OF BACH1 ACTIVITY | 11 | 3.97e-01 | 0.148000 | 6.30e-01 |
SIGNALING BY FGFR3 | 35 | 1.32e-01 | 0.147000 | 3.19e-01 |
PROLACTIN RECEPTOR SIGNALING | 11 | 3.99e-01 | 0.147000 | 6.31e-01 |
SELECTIVE AUTOPHAGY | 71 | 3.23e-02 | 0.147000 | 1.29e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 14 | 3.46e-01 | 0.146000 | 5.81e-01 |
SHC1 EVENTS IN EGFR SIGNALING | 11 | 4.03e-01 | -0.145000 | 6.36e-01 |
EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 1.91e-01 | 0.145000 | 4.01e-01 |
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 3.83e-01 | 0.145000 | 6.18e-01 |
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 1.08e-01 | 0.145000 | 2.78e-01 |
REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 29 | 1.76e-01 | -0.145000 | 3.80e-01 |
ACYL CHAIN REMODELLING OF PC | 18 | 2.87e-01 | 0.145000 | 5.21e-01 |
TRANSPORT OF SMALL MOLECULES | 586 | 2.25e-09 | 0.145000 | 2.95e-07 |
NEGATIVE REGULATION OF MAPK PATHWAY | 42 | 1.05e-01 | 0.144000 | 2.74e-01 |
CLASS B 2 SECRETIN FAMILY RECEPTORS | 72 | 3.43e-02 | 0.144000 | 1.34e-01 |
PKMTS METHYLATE HISTONE LYSINES | 51 | 7.49e-02 | -0.144000 | 2.19e-01 |
RHOBTB GTPASE CYCLE | 35 | 1.41e-01 | 0.144000 | 3.33e-01 |
TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 2.05e-01 | 0.144000 | 4.20e-01 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 2.33e-01 | 0.144000 | 4.54e-01 |
PYRIMIDINE SALVAGE | 10 | 4.31e-01 | 0.144000 | 6.56e-01 |
REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 11 | 4.13e-01 | 0.143000 | 6.42e-01 |
RHO GTPASES ACTIVATE NADPH OXIDASES | 21 | 2.58e-01 | 0.142000 | 4.85e-01 |
LAGGING STRAND SYNTHESIS | 20 | 2.71e-01 | 0.142000 | 5.02e-01 |
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 2.09e-01 | 0.142000 | 4.27e-01 |
RRNA PROCESSING | 194 | 6.48e-04 | -0.142000 | 8.30e-03 |
SIGNALING BY EGFR IN CANCER | 22 | 2.49e-01 | -0.142000 | 4.72e-01 |
SEPARATION OF SISTER CHROMATIDS | 166 | 1.62e-03 | 0.142000 | 1.69e-02 |
SNRNP ASSEMBLY | 51 | 8.08e-02 | 0.141000 | 2.29e-01 |
ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 4.39e-01 | 0.141000 | 6.58e-01 |
RNA POLYMERASE III TRANSCRIPTION | 41 | 1.18e-01 | -0.141000 | 2.98e-01 |
ONCOGENIC MAPK SIGNALING | 77 | 3.24e-02 | 0.141000 | 1.29e-01 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 2.14e-01 | 0.141000 | 4.33e-01 |
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 74 | 3.66e-02 | 0.141000 | 1.41e-01 |
SIGNALING BY GPCR | 486 | 1.28e-07 | 0.140000 | 1.01e-05 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 4.44e-01 | 0.140000 | 6.62e-01 |
NOD1 2 SIGNALING PATHWAY | 35 | 1.52e-01 | 0.140000 | 3.49e-01 |
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 1.42e-01 | -0.140000 | 3.35e-01 |
MITOPHAGY | 29 | 1.94e-01 | 0.139000 | 4.03e-01 |
SIGNALING BY FGFR2 IN DISEASE | 37 | 1.43e-01 | -0.139000 | 3.35e-01 |
SIGNALING BY BRAF AND RAF FUSIONS | 60 | 6.25e-02 | 0.139000 | 1.97e-01 |
PLASMA LIPOPROTEIN REMODELING | 14 | 3.69e-01 | 0.139000 | 6.06e-01 |
TOLL LIKE RECEPTOR CASCADES | 139 | 4.89e-03 | 0.138000 | 3.67e-02 |
CELLULAR RESPONSE TO STARVATION | 146 | 4.06e-03 | -0.138000 | 3.21e-02 |
SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 6.07e-02 | 0.138000 | 1.94e-01 |
NEGATIVE REGULATION OF FGFR4 SIGNALING | 24 | 2.43e-01 | 0.138000 | 4.64e-01 |
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 22 | 2.65e-01 | 0.137000 | 4.95e-01 |
NUCLEOTIDE SALVAGE | 21 | 2.77e-01 | 0.137000 | 5.08e-01 |
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 85 | 2.99e-02 | 0.136000 | 1.22e-01 |
SIGNALING BY FGFR1 IN DISEASE | 33 | 1.77e-01 | 0.136000 | 3.81e-01 |
MITOTIC PROMETAPHASE | 177 | 1.94e-03 | 0.135000 | 1.88e-02 |
INFLUENZA INFECTION | 145 | 5.10e-03 | -0.135000 | 3.80e-02 |
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 19 | 3.10e-01 | 0.135000 | 5.46e-01 |
PHASE I FUNCTIONALIZATION OF COMPOUNDS | 59 | 7.45e-02 | 0.134000 | 2.19e-01 |
NEGATIVE REGULATION OF FGFR1 SIGNALING | 27 | 2.29e-01 | 0.134000 | 4.51e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 4.04e-01 | -0.134000 | 6.36e-01 |
INTERLEUKIN 6 FAMILY SIGNALING | 20 | 3.01e-01 | 0.134000 | 5.36e-01 |
CELL JUNCTION ORGANIZATION | 73 | 4.87e-02 | 0.133000 | 1.72e-01 |
METABOLISM OF VITAMINS AND COFACTORS | 152 | 4.62e-03 | 0.133000 | 3.56e-02 |
NEDDYLATION | 217 | 7.47e-04 | 0.133000 | 9.23e-03 |
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 40 | 1.46e-01 | -0.133000 | 3.39e-01 |
EPH EPHRIN SIGNALING | 92 | 2.76e-02 | 0.133000 | 1.16e-01 |
INTERLEUKIN 2 FAMILY SIGNALING | 32 | 1.93e-01 | 0.133000 | 4.03e-01 |
ION TRANSPORT BY P TYPE ATPASES | 50 | 1.05e-01 | 0.133000 | 2.74e-01 |
PEXOPHAGY | 11 | 4.47e-01 | 0.132000 | 6.65e-01 |
ESTROGEN DEPENDENT GENE EXPRESSION | 107 | 1.86e-02 | -0.132000 | 8.95e-02 |
BASE EXCISION REPAIR | 60 | 7.77e-02 | -0.132000 | 2.23e-01 |
UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 28 | 2.29e-01 | 0.131000 | 4.51e-01 |
GLUCAGON TYPE LIGAND RECEPTORS | 26 | 2.47e-01 | -0.131000 | 4.69e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 2.31e-01 | -0.131000 | 4.53e-01 |
PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 2.33e-01 | -0.130000 | 4.54e-01 |
CROSSLINKING OF COLLAGEN FIBRILS | 15 | 3.83e-01 | -0.130000 | 6.18e-01 |
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 4.78e-01 | -0.129000 | 6.92e-01 |
CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 11 | 4.59e-01 | 0.129000 | 6.79e-01 |
ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 1.45e-01 | 0.129000 | 3.39e-01 |
EXTRA NUCLEAR ESTROGEN SIGNALING | 68 | 6.70e-02 | 0.128000 | 2.08e-01 |
BIOLOGICAL OXIDATIONS | 126 | 1.30e-02 | 0.128000 | 7.27e-02 |
TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 94 | 3.17e-02 | 0.128000 | 1.28e-01 |
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 39 | 1.66e-01 | 0.128000 | 3.66e-01 |
CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 3.34e-01 | -0.128000 | 5.72e-01 |
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 14 | 4.07e-01 | 0.128000 | 6.37e-01 |
NEUTROPHIL DEGRANULATION | 389 | 1.61e-05 | 0.128000 | 5.81e-04 |
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 3.26e-01 | 0.127000 | 5.64e-01 |
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 15 | 3.96e-01 | 0.127000 | 6.29e-01 |
CGMP EFFECTS | 15 | 3.96e-01 | -0.127000 | 6.29e-01 |
SIGNALING BY PTK6 | 51 | 1.19e-01 | 0.126000 | 2.98e-01 |
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 1.53e-01 | -0.126000 | 3.50e-01 |
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 68 | 7.28e-02 | -0.126000 | 2.17e-01 |
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 51 | 1.20e-01 | 0.126000 | 3.01e-01 |
GLYCOLYSIS | 67 | 7.50e-02 | 0.126000 | 2.19e-01 |
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 4.71e-01 | 0.126000 | 6.88e-01 |
PHASE II CONJUGATION OF COMPOUNDS | 64 | 8.24e-02 | 0.126000 | 2.32e-01 |
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 6.40e-02 | 0.125000 | 2.00e-01 |
HEMOSTASIS | 479 | 2.84e-06 | 0.125000 | 1.52e-04 |
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 13 | 4.35e-01 | -0.125000 | 6.58e-01 |
SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 4.54e-01 | 0.125000 | 6.74e-01 |
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 1.67e-01 | 0.125000 | 3.67e-01 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 4.39e-01 | -0.124000 | 6.58e-01 |
CELL CELL JUNCTION ORGANIZATION | 48 | 1.38e-01 | 0.124000 | 3.30e-01 |
ADHERENS JUNCTIONS INTERACTIONS | 30 | 2.41e-01 | 0.124000 | 4.61e-01 |
TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 2.13e-01 | 0.124000 | 4.33e-01 |
S PHASE | 155 | 8.05e-03 | 0.123000 | 5.21e-02 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 20 | 3.42e-01 | -0.123000 | 5.77e-01 |
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 34 | 2.17e-01 | 0.122000 | 4.38e-01 |
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 69 | 8.00e-02 | -0.122000 | 2.29e-01 |
REDUCTION OF CYTOSOLIC CA LEVELS | 12 | 4.65e-01 | 0.122000 | 6.83e-01 |
TRIGLYCERIDE CATABOLISM | 14 | 4.31e-01 | 0.122000 | 6.56e-01 |
GAP JUNCTION TRAFFICKING AND REGULATION | 33 | 2.28e-01 | 0.121000 | 4.51e-01 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 3.74e-01 | 0.121000 | 6.11e-01 |
REPRODUCTION | 80 | 6.16e-02 | -0.121000 | 1.97e-01 |
PI3K AKT SIGNALING IN CANCER | 91 | 4.63e-02 | 0.121000 | 1.65e-01 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 3.38e-01 | 0.121000 | 5.75e-01 |
PLASMA LIPOPROTEIN ASSEMBLY | 12 | 4.69e-01 | 0.121000 | 6.87e-01 |
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 5.46e-02 | 0.121000 | 1.84e-01 |
G ALPHA Q SIGNALLING EVENTS | 155 | 9.67e-03 | 0.121000 | 5.91e-02 |
SUMOYLATION OF TRANSCRIPTION FACTORS | 18 | 3.77e-01 | -0.120000 | 6.11e-01 |
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 4.73e-01 | 0.120000 | 6.90e-01 |
MITOTIC G1 PHASE AND G1 S TRANSITION | 143 | 1.38e-02 | 0.119000 | 7.45e-02 |
RRNA PROCESSING IN THE MITOCHONDRION | 10 | 5.14e-01 | 0.119000 | 7.11e-01 |
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 52 | 1.37e-01 | -0.119000 | 3.29e-01 |
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 3.23e-01 | -0.119000 | 5.61e-01 |
BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 2.93e-01 | 0.119000 | 5.30e-01 |
HEDGEHOG ON STATE | 82 | 6.41e-02 | 0.118000 | 2.00e-01 |
HIV INFECTION | 221 | 2.47e-03 | 0.118000 | 2.24e-02 |
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 3.07e-01 | 0.118000 | 5.42e-01 |
ATTENUATION PHASE | 23 | 3.29e-01 | -0.118000 | 5.67e-01 |
CRISTAE FORMATION | 31 | 2.58e-01 | -0.117000 | 4.85e-01 |
DISEASES OF CARBOHYDRATE METABOLISM | 29 | 2.74e-01 | 0.117000 | 5.06e-01 |
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 3.89e-01 | 0.117000 | 6.24e-01 |
MICRORNA MIRNA BIOGENESIS | 24 | 3.21e-01 | -0.117000 | 5.58e-01 |
PREGNENOLONE BIOSYNTHESIS | 12 | 4.83e-01 | -0.117000 | 6.95e-01 |
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 13 | 4.65e-01 | 0.117000 | 6.83e-01 |
SIGNALLING TO RAS | 20 | 3.66e-01 | 0.117000 | 6.02e-01 |
SHC MEDIATED CASCADE FGFR1 | 16 | 4.19e-01 | -0.117000 | 6.48e-01 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 4.06e-01 | 0.116000 | 6.37e-01 |
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 3.05e-01 | 0.116000 | 5.39e-01 |
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 5.05e-01 | -0.116000 | 7.07e-01 |
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 4.36e-01 | 0.116000 | 6.58e-01 |
REGULATION OF FZD BY UBIQUITINATION | 19 | 3.82e-01 | 0.116000 | 6.18e-01 |
ECM PROTEOGLYCANS | 68 | 9.97e-02 | -0.116000 | 2.65e-01 |
RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 4.39e-01 | 0.115000 | 6.58e-01 |
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 45 | 1.80e-01 | 0.115000 | 3.85e-01 |
INITIAL TRIGGERING OF COMPLEMENT | 12 | 4.90e-01 | 0.115000 | 6.97e-01 |
TIE2 SIGNALING | 17 | 4.12e-01 | 0.115000 | 6.42e-01 |
O LINKED GLYCOSYLATION | 86 | 6.63e-02 | 0.115000 | 2.06e-01 |
ERBB2 ACTIVATES PTK6 SIGNALING | 12 | 4.92e-01 | 0.114000 | 6.98e-01 |
ION HOMEOSTASIS | 50 | 1.62e-01 | 0.114000 | 3.60e-01 |
SIGNALING BY RECEPTOR TYROSINE KINASES | 466 | 2.59e-05 | 0.114000 | 7.96e-04 |
INNATE IMMUNE SYSTEM | 784 | 7.26e-08 | 0.114000 | 6.58e-06 |
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 5.16e-01 | 0.113000 | 7.12e-01 |
SODIUM CALCIUM EXCHANGERS | 10 | 5.37e-01 | 0.113000 | 7.28e-01 |
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 68 | 1.10e-01 | 0.112000 | 2.83e-01 |
SIGNALING BY ERBB2 ECD MUTANTS | 16 | 4.40e-01 | -0.111000 | 6.58e-01 |
EARLY PHASE OF HIV LIFE CYCLE | 13 | 4.87e-01 | -0.111000 | 6.96e-01 |
COLLAGEN FORMATION | 79 | 8.81e-02 | -0.111000 | 2.43e-01 |
DISEASES OF PROGRAMMED CELL DEATH | 57 | 1.47e-01 | -0.111000 | 3.40e-01 |
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 36 | 2.49e-01 | 0.111000 | 4.72e-01 |
INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 284 | 1.32e-03 | 0.111000 | 1.43e-02 |
EPH EPHRIN MEDIATED REPULSION OF CELLS | 51 | 1.71e-01 | 0.111000 | 3.73e-01 |
TRANSLESION SYNTHESIS BY POLK | 17 | 4.29e-01 | -0.111000 | 6.56e-01 |
GLUTATHIONE CONJUGATION | 30 | 2.94e-01 | 0.111000 | 5.30e-01 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 5.44e-01 | 0.111000 | 7.30e-01 |
CHEMOKINE RECEPTORS BIND CHEMOKINES | 17 | 4.30e-01 | -0.110000 | 6.56e-01 |
RNA POLYMERASE I TRANSCRIPTION | 70 | 1.10e-01 | -0.110000 | 2.83e-01 |
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 4.32e-01 | 0.110000 | 6.56e-01 |
SARS COV INFECTIONS | 140 | 2.49e-02 | 0.110000 | 1.09e-01 |
REGULATION OF GENE EXPRESSION IN BETA CELLS | 12 | 5.10e-01 | -0.110000 | 7.09e-01 |
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 39 | 2.41e-01 | 0.108000 | 4.61e-01 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 4.99e-01 | -0.108000 | 7.03e-01 |
ADAPTIVE IMMUNE SYSTEM | 610 | 5.51e-06 | 0.108000 | 2.82e-04 |
HIV TRANSCRIPTION ELONGATION | 42 | 2.26e-01 | -0.108000 | 4.48e-01 |
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 64 | 1.38e-01 | 0.107000 | 3.29e-01 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 4.72e-01 | 0.107000 | 6.89e-01 |
TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 5.40e-01 | 0.107000 | 7.29e-01 |
TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 3.30e-01 | 0.106000 | 5.68e-01 |
TFAP2 AP 2 FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS | 11 | 5.42e-01 | -0.106000 | 7.29e-01 |
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 86 | 8.91e-02 | -0.106000 | 2.45e-01 |
NUCLEAR SIGNALING BY ERBB4 | 31 | 3.07e-01 | 0.106000 | 5.42e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 4.78e-01 | 0.106000 | 6.92e-01 |
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 4.93e-01 | -0.106000 | 6.98e-01 |
RHO GTPASES ACTIVATE CIT | 18 | 4.39e-01 | -0.105000 | 6.58e-01 |
ERBB2 REGULATES CELL MOTILITY | 14 | 4.95e-01 | 0.105000 | 7.01e-01 |
PHASE 0 RAPID DEPOLARISATION | 28 | 3.39e-01 | -0.104000 | 5.75e-01 |
NICOTINATE METABOLISM | 24 | 3.76e-01 | 0.104000 | 6.11e-01 |
RHO GTPASE EFFECTORS | 253 | 4.40e-03 | 0.104000 | 3.42e-02 |
RHO GTPASES ACTIVATE IQGAPS | 24 | 3.78e-01 | 0.104000 | 6.12e-01 |
ABC FAMILY PROTEINS MEDIATED TRANSPORT | 95 | 8.02e-02 | 0.104000 | 2.29e-01 |
SIGNALING BY NTRK3 TRKC | 17 | 4.60e-01 | -0.103000 | 6.80e-01 |
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 286 | 2.68e-03 | 0.103000 | 2.36e-02 |
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 19 | 4.37e-01 | 0.103000 | 6.58e-01 |
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 37 | 2.79e-01 | 0.103000 | 5.11e-01 |
LYSOSPHINGOLIPID AND LPA RECEPTORS | 13 | 5.22e-01 | -0.103000 | 7.14e-01 |
FC EPSILON RECEPTOR FCERI SIGNALING | 123 | 5.07e-02 | 0.102000 | 1.76e-01 |
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 4.30e-01 | 0.102000 | 6.56e-01 |
HEDGEHOG LIGAND BIOGENESIS | 61 | 1.70e-01 | 0.102000 | 3.71e-01 |
DISEASES OF METABOLISM | 198 | 1.42e-02 | 0.101000 | 7.59e-02 |
M PHASE | 343 | 1.33e-03 | 0.101000 | 1.43e-02 |
SMOOTH MUSCLE CONTRACTION | 33 | 3.16e-01 | -0.101000 | 5.52e-01 |
EPIGENETIC REGULATION OF GENE EXPRESSION | 106 | 7.29e-02 | -0.101000 | 2.17e-01 |
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 58 | 1.84e-01 | 0.101000 | 3.91e-01 |
L1CAM INTERACTIONS | 108 | 7.08e-02 | 0.101000 | 2.16e-01 |
POLYMERASE SWITCHING | 14 | 5.14e-01 | 0.101000 | 7.11e-01 |
HCMV INFECTION | 106 | 7.35e-02 | 0.101000 | 2.19e-01 |
PLATELET AGGREGATION PLUG FORMATION | 32 | 3.25e-01 | 0.101000 | 5.64e-01 |
SIGNALING BY ROBO RECEPTORS | 207 | 1.30e-02 | -0.100000 | 7.27e-02 |
G PROTEIN ACTIVATION | 23 | 4.06e-01 | -0.100000 | 6.37e-01 |
DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 369 | 9.89e-04 | 0.100000 | 1.14e-02 |
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 34 | 3.14e-01 | 0.099700 | 5.51e-01 |
FGFRL1 MODULATION OF FGFR1 SIGNALING | 10 | 5.86e-01 | -0.099400 | 7.64e-01 |
MITOTIC PROPHASE | 97 | 9.10e-02 | 0.099400 | 2.47e-01 |
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 12 | 5.51e-01 | -0.099300 | 7.35e-01 |
SIGNALING BY TGFB FAMILY MEMBERS | 97 | 9.11e-02 | 0.099300 | 2.47e-01 |
CELL CYCLE MITOTIC | 479 | 2.11e-04 | 0.099100 | 3.50e-03 |
CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 5.09e-01 | -0.098600 | 7.07e-01 |
SIGNALING BY LEPTIN | 10 | 5.89e-01 | 0.098600 | 7.65e-01 |
P38MAPK EVENTS | 13 | 5.39e-01 | 0.098400 | 7.28e-01 |
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 53 | 2.16e-01 | 0.098300 | 4.35e-01 |
REPRESSION OF WNT TARGET GENES | 14 | 5.25e-01 | -0.098200 | 7.16e-01 |
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 92 | 1.05e-01 | 0.097800 | 2.74e-01 |
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 3.39e-01 | -0.097800 | 5.75e-01 |
SIGNALING BY FLT3 FUSION PROTEINS | 19 | 4.62e-01 | -0.097400 | 6.81e-01 |
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 4.63e-01 | 0.097200 | 6.81e-01 |
FGFR1 LIGAND BINDING AND ACTIVATION | 10 | 5.95e-01 | -0.097100 | 7.68e-01 |
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 347 | 2.07e-03 | 0.096400 | 1.95e-02 |
NCAM SIGNALING FOR NEURITE OUT GROWTH | 62 | 1.91e-01 | -0.096200 | 4.01e-01 |
REGULATION OF IFNA SIGNALING | 12 | 5.65e-01 | 0.096000 | 7.49e-01 |
HEDGEHOG OFF STATE | 106 | 8.80e-02 | 0.096000 | 2.43e-01 |
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 36 | 3.21e-01 | 0.095700 | 5.58e-01 |
GROWTH HORMONE RECEPTOR SIGNALING | 20 | 4.63e-01 | 0.094900 | 6.81e-01 |
NEUREXINS AND NEUROLIGINS | 54 | 2.29e-01 | 0.094800 | 4.51e-01 |
RHO GTPASES ACTIVATE ROCKS | 19 | 4.75e-01 | -0.094700 | 6.90e-01 |
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 5.72e-01 | 0.094300 | 7.53e-01 |
LATE ENDOSOMAL MICROAUTOPHAGY | 31 | 3.68e-01 | 0.093400 | 6.06e-01 |
TRP CHANNELS | 20 | 4.70e-01 | 0.093200 | 6.88e-01 |
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 25 | 4.20e-01 | -0.093100 | 6.49e-01 |
TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 3.58e-01 | 0.092500 | 5.94e-01 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 4.75e-01 | 0.092400 | 6.90e-01 |
SIGNALING BY FGFR4 | 34 | 3.52e-01 | 0.092300 | 5.87e-01 |
NEGATIVE REGULATION OF FGFR2 SIGNALING | 28 | 3.98e-01 | 0.092200 | 6.31e-01 |
ANCHORING FIBRIL FORMATION | 14 | 5.50e-01 | -0.092200 | 7.35e-01 |
METABOLISM OF FAT SOLUBLE VITAMINS | 32 | 3.69e-01 | 0.091900 | 6.06e-01 |
LEISHMANIA INFECTION | 198 | 2.67e-02 | 0.091400 | 1.14e-01 |
REGULATION OF TP53 ACTIVITY | 152 | 5.24e-02 | 0.091200 | 1.81e-01 |
INWARDLY RECTIFYING K CHANNELS | 32 | 3.73e-01 | 0.090900 | 6.11e-01 |
SIGNALING BY ERBB2 | 49 | 2.72e-01 | 0.090800 | 5.02e-01 |
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 4.96e-01 | -0.090200 | 7.01e-01 |
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 17 | 5.21e-01 | -0.089900 | 7.14e-01 |
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 4.88e-01 | -0.089600 | 6.96e-01 |
REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 63 | 2.19e-01 | 0.089500 | 4.39e-01 |
GPCR LIGAND BINDING | 270 | 1.16e-02 | 0.089400 | 6.71e-02 |
RHOH GTPASE CYCLE | 37 | 3.47e-01 | 0.089300 | 5.82e-01 |
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 58 | 2.40e-01 | 0.089300 | 4.61e-01 |
SIGNALING BY INSULIN RECEPTOR | 65 | 2.13e-01 | 0.089300 | 4.33e-01 |
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 62 | 2.25e-01 | 0.089100 | 4.48e-01 |
LAMININ INTERACTIONS | 29 | 4.07e-01 | -0.089100 | 6.37e-01 |
SIGNALING BY FGFR4 IN DISEASE | 11 | 6.10e-01 | -0.088900 | 7.76e-01 |
PROCESSING OF SMDT1 | 16 | 5.39e-01 | 0.088800 | 7.28e-01 |
RORA ACTIVATES GENE EXPRESSION | 18 | 5.14e-01 | 0.088800 | 7.11e-01 |
ION CHANNEL TRANSPORT | 143 | 6.78e-02 | 0.088500 | 2.10e-01 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 6.12e-01 | -0.088300 | 7.76e-01 |
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 5.96e-01 | -0.088300 | 7.69e-01 |
DISEASES OF GLYCOSYLATION | 124 | 9.01e-02 | 0.088200 | 2.47e-01 |
PLATELET HOMEOSTASIS | 78 | 1.79e-01 | 0.088100 | 3.84e-01 |
HIV LIFE CYCLE | 142 | 7.12e-02 | 0.087800 | 2.16e-01 |
TELOMERE MAINTENANCE | 81 | 1.73e-01 | -0.087700 | 3.75e-01 |
FLT3 SIGNALING | 36 | 3.64e-01 | 0.087500 | 6.00e-01 |
TERMINATION OF TRANSLESION DNA SYNTHESIS | 32 | 3.93e-01 | -0.087200 | 6.29e-01 |
RUNX2 REGULATES BONE DEVELOPMENT | 29 | 4.18e-01 | 0.087000 | 6.47e-01 |
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 3.95e-01 | 0.086800 | 6.29e-01 |
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 2.99e-01 | 0.086700 | 5.34e-01 |
SIGNALING BY NOTCH3 | 48 | 3.02e-01 | 0.086100 | 5.37e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 20 | 5.07e-01 | 0.085800 | 7.07e-01 |
KERATAN SULFATE DEGRADATION | 11 | 6.24e-01 | 0.085500 | 7.85e-01 |
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 21 | 4.98e-01 | -0.085400 | 7.02e-01 |
ONCOGENE INDUCED SENESCENCE | 32 | 4.07e-01 | 0.084700 | 6.37e-01 |
MAPK FAMILY SIGNALING CASCADES | 290 | 1.33e-02 | 0.084600 | 7.32e-02 |
TRANSLESION SYNTHESIS BY POLH | 19 | 5.25e-01 | -0.084200 | 7.16e-01 |
ACYL CHAIN REMODELLING OF PS | 14 | 5.87e-01 | 0.083800 | 7.64e-01 |
HCMV LATE EVENTS | 68 | 2.32e-01 | 0.083800 | 4.54e-01 |
FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 23 | 4.88e-01 | -0.083500 | 6.96e-01 |
OXIDATIVE STRESS INDUCED SENESCENCE | 81 | 1.97e-01 | -0.083000 | 4.07e-01 |
CHOLESTEROL BIOSYNTHESIS | 24 | 4.84e-01 | 0.082500 | 6.95e-01 |
RUNX3 REGULATES NOTCH SIGNALING | 13 | 6.07e-01 | 0.082400 | 7.74e-01 |
ABC TRANSPORTER DISORDERS | 70 | 2.34e-01 | 0.082300 | 4.54e-01 |
PYROPTOSIS | 21 | 5.15e-01 | -0.082100 | 7.11e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 45 | 3.41e-01 | 0.082100 | 5.76e-01 |
VIRAL MESSENGER RNA SYNTHESIS | 42 | 3.60e-01 | 0.081600 | 5.96e-01 |
FRS MEDIATED FGFR3 SIGNALING | 15 | 5.87e-01 | 0.081100 | 7.64e-01 |
INTERLEUKIN 1 FAMILY SIGNALING | 123 | 1.21e-01 | 0.081100 | 3.01e-01 |
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 33 | 4.21e-01 | -0.081000 | 6.49e-01 |
AMYLOID FIBER FORMATION | 61 | 2.74e-01 | -0.080900 | 5.06e-01 |
SIGNALING BY FLT3 ITD AND TKD MUTANTS | 16 | 5.75e-01 | -0.080900 | 7.57e-01 |
NEGATIVE REGULATION OF FLT3 | 14 | 6.02e-01 | 0.080600 | 7.71e-01 |
INTERLEUKIN 1 SIGNALING | 96 | 1.73e-01 | 0.080500 | 3.75e-01 |
SIGNALING BY FGFR1 | 44 | 3.55e-01 | 0.080500 | 5.91e-01 |
SIGNALING BY THE B CELL RECEPTOR BCR | 103 | 1.58e-01 | 0.080500 | 3.57e-01 |
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 2.88e-01 | -0.080000 | 5.22e-01 |
AQUAPORIN MEDIATED TRANSPORT | 41 | 3.75e-01 | 0.080000 | 6.11e-01 |
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 29 | 4.57e-01 | 0.079900 | 6.77e-01 |
ACTIVATION OF BH3 ONLY PROTEINS | 30 | 4.49e-01 | 0.079800 | 6.68e-01 |
METABOLISM OF POLYAMINES | 57 | 3.01e-01 | 0.079200 | 5.36e-01 |
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 5.51e-01 | 0.079100 | 7.35e-01 |
VISUAL PHOTOTRANSDUCTION | 61 | 2.90e-01 | -0.078400 | 5.24e-01 |
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 6.52e-01 | 0.078400 | 8.09e-01 |
UB SPECIFIC PROCESSING PROTEASES | 167 | 8.09e-02 | 0.078400 | 2.29e-01 |
NICOTINAMIDE SALVAGING | 15 | 6.00e-01 | 0.078200 | 7.71e-01 |
DNA REPLICATION PRE INITIATION | 80 | 2.30e-01 | 0.077700 | 4.51e-01 |
INTERACTION BETWEEN L1 AND ANKYRINS | 27 | 4.85e-01 | -0.077700 | 6.95e-01 |
SHC1 EVENTS IN ERBB2 SIGNALING | 21 | 5.38e-01 | 0.077700 | 7.28e-01 |
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 84 | 2.19e-01 | -0.077600 | 4.39e-01 |
REGULATION OF TLR BY ENDOGENOUS LIGAND | 13 | 6.29e-01 | -0.077500 | 7.90e-01 |
DNA DAMAGE RECOGNITION IN GG NER | 38 | 4.09e-01 | 0.077400 | 6.38e-01 |
SIGNALING BY INTERLEUKINS | 351 | 1.34e-02 | 0.077000 | 7.32e-02 |
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 79 | 2.39e-01 | 0.076600 | 4.61e-01 |
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 5.01e-01 | 0.076300 | 7.04e-01 |
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 39 | 4.14e-01 | -0.075600 | 6.44e-01 |
CILIUM ASSEMBLY | 192 | 7.18e-02 | 0.075400 | 2.17e-01 |
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 78 | 2.50e-01 | 0.075400 | 4.73e-01 |
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 5.82e-01 | 0.075000 | 7.63e-01 |
SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 6.83e-01 | 0.074700 | 8.30e-01 |
FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 3.49e-01 | 0.074400 | 5.83e-01 |
FGFR2 ALTERNATIVE SPLICING | 25 | 5.21e-01 | -0.074200 | 7.14e-01 |
GLUCAGON SIGNALING IN METABOLIC REGULATION | 30 | 4.84e-01 | 0.073900 | 6.95e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 20 | 5.69e-01 | 0.073500 | 7.53e-01 |
ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 118 | 1.69e-01 | 0.073300 | 3.71e-01 |
SIGNALING BY ERBB4 | 57 | 3.41e-01 | 0.073000 | 5.76e-01 |
DEGRADATION OF THE EXTRACELLULAR MATRIX | 111 | 1.85e-01 | -0.072900 | 3.92e-01 |
CELL CYCLE | 597 | 2.44e-03 | 0.072800 | 2.23e-02 |
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 6.14e-01 | -0.072800 | 7.76e-01 |
DEUBIQUITINATION | 241 | 5.32e-02 | 0.072400 | 1.81e-01 |
METAL ION SLC TRANSPORTERS | 25 | 5.32e-01 | 0.072200 | 7.24e-01 |
SIGNALING BY NOTCH1 | 75 | 2.81e-01 | 0.072000 | 5.14e-01 |
TRANSLATION | 286 | 3.68e-02 | -0.071900 | 1.42e-01 |
REGULATED NECROSIS | 46 | 4.00e-01 | -0.071800 | 6.32e-01 |
REGULATION OF PTEN STABILITY AND ACTIVITY | 66 | 3.14e-01 | 0.071700 | 5.51e-01 |
REGULATED PROTEOLYSIS OF P75NTR | 12 | 6.68e-01 | 0.071600 | 8.24e-01 |
CELL CYCLE CHECKPOINTS | 245 | 5.46e-02 | 0.071400 | 1.84e-01 |
SYNAPTIC ADHESION LIKE MOLECULES | 21 | 5.71e-01 | 0.071300 | 7.53e-01 |
SIGNALING BY FGFR2 IIIA TM | 19 | 5.90e-01 | -0.071300 | 7.65e-01 |
DNA REPLICATION | 122 | 1.75e-01 | 0.071100 | 3.79e-01 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 6.12e-01 | 0.071100 | 7.76e-01 |
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 5.56e-01 | 0.070900 | 7.40e-01 |
FRS MEDIATED FGFR2 SIGNALING | 19 | 5.93e-01 | -0.070800 | 7.67e-01 |
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 5.84e-01 | 0.070800 | 7.64e-01 |
FORMATION OF INCISION COMPLEX IN GG NER | 43 | 4.22e-01 | 0.070700 | 6.50e-01 |
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 7.01e-01 | 0.070200 | 8.45e-01 |
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 12 | 6.75e-01 | 0.069900 | 8.26e-01 |
METABOLISM OF FOLATE AND PTERINES | 15 | 6.43e-01 | 0.069100 | 8.03e-01 |
RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 5.07e-01 | -0.068900 | 7.07e-01 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 5.43e-01 | 0.068900 | 7.30e-01 |
EPHA MEDIATED GROWTH CONE COLLAPSE | 29 | 5.23e-01 | -0.068600 | 7.14e-01 |
FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 24 | 5.63e-01 | -0.068300 | 7.46e-01 |
REGULATION OF RAS BY GAPS | 66 | 3.38e-01 | 0.068200 | 5.75e-01 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 6.71e-01 | 0.068100 | 8.26e-01 |
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 66 | 3.39e-01 | -0.068100 | 5.75e-01 |
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 6.72e-01 | 0.067900 | 8.26e-01 |
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 46 | 4.28e-01 | -0.067600 | 6.56e-01 |
PINK1 PRKN MEDIATED MITOPHAGY | 22 | 5.84e-01 | 0.067500 | 7.64e-01 |
MITOCHONDRIAL FATTY ACID BETA OXIDATION | 34 | 4.97e-01 | 0.067400 | 7.01e-01 |
TRAFFICKING OF AMPA RECEPTORS | 31 | 5.17e-01 | 0.067300 | 7.12e-01 |
MEIOSIS | 67 | 3.44e-01 | -0.066800 | 5.80e-01 |
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 64 | 3.55e-01 | -0.066800 | 5.91e-01 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 6.77e-01 | -0.066800 | 8.26e-01 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 7.02e-01 | 0.066700 | 8.45e-01 |
INSULIN RECEPTOR SIGNALLING CASCADE | 46 | 4.35e-01 | 0.066600 | 6.58e-01 |
CELLULAR RESPONSE TO CHEMICAL STRESS | 152 | 1.62e-01 | -0.065700 | 3.60e-01 |
GENE SILENCING BY RNA | 85 | 2.95e-01 | -0.065700 | 5.31e-01 |
G2 M DNA DAMAGE CHECKPOINT | 69 | 3.47e-01 | -0.065500 | 5.82e-01 |
KINESINS | 47 | 4.39e-01 | 0.065200 | 6.58e-01 |
CLASS A 1 RHODOPSIN LIKE RECEPTORS | 187 | 1.26e-01 | 0.064900 | 3.09e-01 |
DSCAM INTERACTIONS | 11 | 7.10e-01 | 0.064800 | 8.50e-01 |
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 12 | 6.99e-01 | -0.064600 | 8.45e-01 |
REGULATION OF PTEN GENE TRANSCRIPTION | 58 | 3.95e-01 | 0.064500 | 6.29e-01 |
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 5.94e-01 | 0.064300 | 7.67e-01 |
CHROMOSOME MAINTENANCE | 104 | 2.60e-01 | -0.064000 | 4.87e-01 |
INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 5.89e-01 | -0.063800 | 7.65e-01 |
INTERFERON ALPHA BETA SIGNALING | 54 | 4.18e-01 | -0.063800 | 6.47e-01 |
INTERLEUKIN 7 SIGNALING | 19 | 6.31e-01 | -0.063600 | 7.92e-01 |
RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 6.16e-01 | 0.063200 | 7.78e-01 |
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 4.23e-01 | 0.063100 | 6.50e-01 |
RIPK1 MEDIATED REGULATED NECROSIS | 25 | 5.86e-01 | -0.063000 | 7.64e-01 |
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 6.44e-01 | -0.062900 | 8.04e-01 |
PYRIMIDINE CATABOLISM | 10 | 7.32e-01 | -0.062600 | 8.71e-01 |
RESOLUTION OF D LOOP STRUCTURES | 31 | 5.49e-01 | -0.062200 | 7.35e-01 |
RET SIGNALING | 38 | 5.08e-01 | 0.062100 | 7.07e-01 |
METABOLISM OF AMINO ACIDS AND DERIVATIVES | 317 | 5.84e-02 | 0.061900 | 1.91e-01 |
PURINE CATABOLISM | 16 | 6.71e-01 | 0.061400 | 8.26e-01 |
TRNA PROCESSING | 105 | 2.78e-01 | 0.061300 | 5.10e-01 |
MEIOTIC SYNAPSIS | 43 | 4.98e-01 | -0.059700 | 7.02e-01 |
CYTOKINE SIGNALING IN IMMUNE SYSTEM | 549 | 1.76e-02 | 0.059400 | 8.63e-02 |
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 60 | 4.27e-01 | 0.059400 | 6.55e-01 |
MRNA SPLICING | 188 | 1.62e-01 | -0.059100 | 3.60e-01 |
STRIATED MUSCLE CONTRACTION | 26 | 6.05e-01 | -0.058600 | 7.73e-01 |
PI3K EVENTS IN ERBB2 SIGNALING | 15 | 6.95e-01 | 0.058500 | 8.42e-01 |
MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 6.30e-01 | 0.058100 | 7.91e-01 |
SUMOYLATION OF INTRACELLULAR RECEPTORS | 27 | 6.04e-01 | 0.057700 | 7.73e-01 |
VOLTAGE GATED POTASSIUM CHANNELS | 38 | 5.39e-01 | 0.057600 | 7.28e-01 |
FCERI MEDIATED CA 2 MOBILIZATION | 26 | 6.12e-01 | 0.057500 | 7.76e-01 |
C TYPE LECTIN RECEPTORS CLRS | 112 | 2.95e-01 | 0.057400 | 5.31e-01 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 4.47e-01 | -0.057200 | 6.65e-01 |
CRMPS IN SEMA3A SIGNALING | 16 | 6.92e-01 | -0.057100 | 8.40e-01 |
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 27 | 6.08e-01 | 0.057000 | 7.75e-01 |
TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 6.75e-01 | 0.057000 | 8.26e-01 |
RESOLUTION OF ABASIC SITES AP SITES | 38 | 5.43e-01 | -0.057000 | 7.30e-01 |
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 7.57e-01 | 0.056500 | 8.85e-01 |
FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 5.76e-01 | -0.056300 | 7.57e-01 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 7.47e-01 | 0.056200 | 8.80e-01 |
HCMV EARLY EVENTS | 83 | 3.77e-01 | 0.056200 | 6.11e-01 |
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 74 | 4.08e-01 | -0.055700 | 6.37e-01 |
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 21 | 6.61e-01 | 0.055300 | 8.18e-01 |
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 4.62e-01 | -0.054500 | 6.81e-01 |
DISEASES OF MITOTIC CELL CYCLE | 37 | 5.68e-01 | 0.054300 | 7.51e-01 |
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 5.38e-01 | 0.054300 | 7.28e-01 |
G ALPHA S SIGNALLING EVENTS | 107 | 3.33e-01 | 0.054200 | 5.71e-01 |
SIGNALING BY NOTCH2 | 33 | 5.91e-01 | 0.054000 | 7.65e-01 |
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 31 | 6.05e-01 | 0.053700 | 7.73e-01 |
ORGANELLE BIOGENESIS AND MAINTENANCE | 284 | 1.23e-01 | 0.053300 | 3.04e-01 |
PROTEIN FOLDING | 90 | 3.86e-01 | 0.052900 | 6.21e-01 |
GAP JUNCTION ASSEMBLY | 21 | 6.75e-01 | 0.052800 | 8.26e-01 |
INFECTIOUS DISEASE | 736 | 1.52e-02 | 0.052800 | 7.83e-02 |
INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 5.12e-01 | 0.052600 | 7.10e-01 |
TP53 REGULATES METABOLIC GENES | 85 | 4.03e-01 | -0.052500 | 6.36e-01 |
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 4.89e-01 | 0.052100 | 6.96e-01 |
OVARIAN TUMOR DOMAIN PROTEASES | 36 | 5.89e-01 | 0.052000 | 7.65e-01 |
IRAK4 DEFICIENCY TLR2 4 | 14 | 7.37e-01 | -0.051900 | 8.75e-01 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 2.45e-01 | -0.051400 | 4.67e-01 |
MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 33 | 6.11e-01 | 0.051200 | 7.76e-01 |
CARDIAC CONDUCTION | 107 | 3.62e-01 | 0.051000 | 5.98e-01 |
TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 6.02e-01 | -0.051000 | 7.71e-01 |
RAS PROCESSING | 24 | 6.66e-01 | 0.050900 | 8.22e-01 |
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 6.73e-01 | 0.050800 | 8.26e-01 |
MATURATION OF NUCLEOPROTEIN | 10 | 7.81e-01 | -0.050800 | 8.94e-01 |
TCR SIGNALING | 101 | 3.84e-01 | 0.050100 | 6.19e-01 |
TNFR2 NON CANONICAL NF KB PATHWAY | 82 | 4.35e-01 | 0.049900 | 6.58e-01 |
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 84 | 4.36e-01 | 0.049200 | 6.58e-01 |
FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 5.22e-01 | -0.049000 | 7.14e-01 |
RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 15 | 7.44e-01 | -0.048800 | 8.80e-01 |
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 14 | 7.53e-01 | 0.048600 | 8.83e-01 |
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 25 | 6.76e-01 | -0.048200 | 8.26e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 24 | 6.85e-01 | 0.047900 | 8.32e-01 |
OTHER SEMAPHORIN INTERACTIONS | 19 | 7.18e-01 | -0.047800 | 8.57e-01 |
HOMOLOGY DIRECTED REPAIR | 111 | 3.87e-01 | -0.047600 | 6.21e-01 |
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 13 | 7.67e-01 | 0.047500 | 8.88e-01 |
PRE NOTCH EXPRESSION AND PROCESSING | 67 | 5.02e-01 | -0.047500 | 7.04e-01 |
ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 94 | 4.31e-01 | 0.047000 | 6.56e-01 |
EXTENSION OF TELOMERES | 49 | 5.70e-01 | 0.046900 | 7.53e-01 |
APOPTOTIC EXECUTION PHASE | 45 | 5.87e-01 | 0.046800 | 7.64e-01 |
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 64 | 5.17e-01 | 0.046800 | 7.12e-01 |
GAB1 SIGNALOSOME | 14 | 7.63e-01 | 0.046500 | 8.86e-01 |
INTERFERON GAMMA SIGNALING | 76 | 4.84e-01 | -0.046500 | 6.95e-01 |
STIMULI SENSING CHANNELS | 76 | 4.85e-01 | 0.046400 | 6.95e-01 |
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 7.57e-01 | 0.046100 | 8.85e-01 |
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 5.41e-01 | -0.046000 | 7.29e-01 |
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 33 | 6.48e-01 | 0.045900 | 8.08e-01 |
FCERI MEDIATED NF KB ACTIVATION | 76 | 4.91e-01 | 0.045800 | 6.97e-01 |
CYTOPROTECTION BY HMOX1 | 120 | 3.88e-01 | -0.045600 | 6.23e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 24 | 6.99e-01 | -0.045500 | 8.45e-01 |
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 13 | 7.77e-01 | 0.045400 | 8.94e-01 |
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 7.08e-01 | 0.045100 | 8.50e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 7.64e-01 | -0.044800 | 8.86e-01 |
ENDOSOMAL VACUOLAR PATHWAY | 10 | 8.06e-01 | 0.044800 | 9.14e-01 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 13 | 7.83e-01 | -0.044200 | 8.95e-01 |
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 7.69e-01 | -0.043800 | 8.89e-01 |
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 31 | 6.73e-01 | -0.043800 | 8.26e-01 |
TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 64 | 5.45e-01 | -0.043800 | 7.30e-01 |
MAP2K AND MAPK ACTIVATION | 36 | 6.50e-01 | 0.043700 | 8.09e-01 |
APC CDC20 MEDIATED DEGRADATION OF NEK2A | 24 | 7.12e-01 | 0.043500 | 8.52e-01 |
ZINC TRANSPORTERS | 16 | 7.64e-01 | 0.043400 | 8.86e-01 |
PCP CE PATHWAY | 89 | 4.80e-01 | 0.043400 | 6.93e-01 |
HDR THROUGH SINGLE STRAND ANNEALING SSA | 37 | 6.49e-01 | -0.043300 | 8.08e-01 |
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 6.78e-01 | 0.043100 | 8.27e-01 |
UCH PROTEINASES | 89 | 4.83e-01 | -0.043000 | 6.95e-01 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 7.61e-01 | -0.042600 | 8.86e-01 |
COMPLEMENT CASCADE | 26 | 7.08e-01 | 0.042400 | 8.50e-01 |
SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 8.10e-01 | -0.041900 | 9.15e-01 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 5.99e-01 | -0.041800 | 7.71e-01 |
FRS MEDIATED FGFR4 SIGNALING | 15 | 7.80e-01 | -0.041700 | 8.94e-01 |
GRB2 EVENTS IN ERBB2 SIGNALING | 15 | 7.81e-01 | -0.041400 | 8.94e-01 |
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 81 | 5.20e-01 | 0.041400 | 7.14e-01 |
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 6.22e-01 | 0.041100 | 7.84e-01 |
POTASSIUM CHANNELS | 90 | 5.03e-01 | 0.040900 | 7.05e-01 |
SIGNALING BY PDGFR IN DISEASE | 20 | 7.52e-01 | 0.040800 | 8.83e-01 |
PROGRAMMED CELL DEATH | 186 | 3.38e-01 | 0.040800 | 5.75e-01 |
IRS MEDIATED SIGNALLING | 41 | 6.52e-01 | 0.040800 | 8.09e-01 |
HDMS DEMETHYLATE HISTONES | 30 | 7.01e-01 | -0.040500 | 8.45e-01 |
INTRAFLAGELLAR TRANSPORT | 52 | 6.14e-01 | 0.040400 | 7.76e-01 |
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 5.37e-01 | 0.040200 | 7.28e-01 |
SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 5.57e-01 | 0.040100 | 7.40e-01 |
SEMA4D IN SEMAPHORIN SIGNALING | 24 | 7.35e-01 | 0.039900 | 8.74e-01 |
SUMOYLATION | 168 | 3.74e-01 | 0.039800 | 6.11e-01 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 7.97e-01 | 0.039700 | 9.06e-01 |
CLEC7A DECTIN 1 SIGNALING | 94 | 5.08e-01 | 0.039600 | 7.07e-01 |
DNA DOUBLE STRAND BREAK RESPONSE | 55 | 6.14e-01 | 0.039400 | 7.76e-01 |
REGULATION OF LIPID METABOLISM BY PPARALPHA | 108 | 4.86e-01 | 0.038800 | 6.96e-01 |
ASSEMBLY OF THE HIV VIRION | 16 | 7.91e-01 | 0.038300 | 9.01e-01 |
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 24 | 7.46e-01 | -0.038300 | 8.80e-01 |
NON INTEGRIN MEMBRANE ECM INTERACTIONS | 57 | 6.18e-01 | -0.038200 | 7.80e-01 |
METHYLATION | 11 | 8.28e-01 | 0.037700 | 9.22e-01 |
INTERLEUKIN 20 FAMILY SIGNALING | 14 | 8.07e-01 | 0.037700 | 9.14e-01 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 8.39e-01 | -0.037100 | 9.27e-01 |
METABOLISM OF STEROID HORMONES | 21 | 7.70e-01 | 0.036900 | 8.89e-01 |
CHROMATIN MODIFYING ENZYMES | 222 | 3.48e-01 | -0.036600 | 5.83e-01 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 8.21e-01 | 0.036300 | 9.19e-01 |
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 88 | 5.62e-01 | -0.035800 | 7.46e-01 |
RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 25 | 7.58e-01 | -0.035600 | 8.85e-01 |
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 82 | 5.78e-01 | 0.035600 | 7.59e-01 |
INTERFERON SIGNALING | 164 | 4.35e-01 | 0.035300 | 6.58e-01 |
METABOLISM OF RNA | 645 | 1.28e-01 | -0.035200 | 3.12e-01 |
ELASTIC FIBRE FORMATION | 38 | 7.08e-01 | 0.035100 | 8.50e-01 |
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 8.29e-01 | 0.034500 | 9.23e-01 |
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 15 | 8.20e-01 | 0.033900 | 9.19e-01 |
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 7.42e-01 | -0.033700 | 8.80e-01 |
STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS | 10 | 8.54e-01 | -0.033600 | 9.35e-01 |
PI 3K CASCADE FGFR2 | 17 | 8.11e-01 | -0.033500 | 9.15e-01 |
PTEN REGULATION | 133 | 5.07e-01 | 0.033400 | 7.07e-01 |
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 85 | 6.02e-01 | 0.032800 | 7.71e-01 |
DISEASES OF IMMUNE SYSTEM | 26 | 7.73e-01 | -0.032700 | 8.92e-01 |
HSF1 DEPENDENT TRANSACTIVATION | 33 | 7.47e-01 | 0.032500 | 8.80e-01 |
APOPTOSIS | 164 | 4.75e-01 | 0.032300 | 6.90e-01 |
G1 S DNA DAMAGE CHECKPOINTS | 65 | 6.53e-01 | -0.032300 | 8.09e-01 |
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 23 | 7.91e-01 | 0.031900 | 9.01e-01 |
SHC1 EVENTS IN ERBB4 SIGNALING | 13 | 8.43e-01 | 0.031700 | 9.29e-01 |
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 29 | 7.68e-01 | 0.031600 | 8.89e-01 |
ENOS ACTIVATION | 11 | 8.60e-01 | 0.030800 | 9.36e-01 |
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 8.66e-01 | 0.030800 | 9.39e-01 |
MITOTIC G2 G2 M PHASES | 184 | 4.76e-01 | 0.030500 | 6.90e-01 |
SIGNALING BY WNT | 272 | 3.91e-01 | 0.030300 | 6.26e-01 |
INFLAMMASOMES | 19 | 8.20e-01 | 0.030100 | 9.19e-01 |
HSF1 ACTIVATION | 25 | 7.96e-01 | -0.029800 | 9.06e-01 |
DUAL INCISION IN TC NER | 65 | 6.79e-01 | -0.029700 | 8.27e-01 |
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 64 | 6.81e-01 | 0.029700 | 8.29e-01 |
POTENTIAL THERAPEUTICS FOR SARS | 77 | 6.53e-01 | 0.029700 | 8.09e-01 |
SIGNALING BY NUCLEAR RECEPTORS | 228 | 4.44e-01 | 0.029500 | 6.62e-01 |
PHOSPHORYLATION OF THE APC C | 17 | 8.36e-01 | 0.029100 | 9.27e-01 |
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 86 | 6.42e-01 | 0.029000 | 8.03e-01 |
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 41 | 7.48e-01 | -0.029000 | 8.80e-01 |
PI 3K CASCADE FGFR1 | 16 | 8.42e-01 | 0.028900 | 9.29e-01 |
PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 8.52e-01 | -0.028800 | 9.35e-01 |
DEGRADATION OF GLI1 BY THE PROTEASOME | 57 | 7.09e-01 | 0.028600 | 8.50e-01 |
ACTIVATION OF MATRIX METALLOPROTEINASES | 15 | 8.48e-01 | 0.028500 | 9.33e-01 |
MITOCHONDRIAL PROTEIN IMPORT | 63 | 6.99e-01 | 0.028200 | 8.45e-01 |
CA2 PATHWAY | 59 | 7.10e-01 | -0.028000 | 8.50e-01 |
INTERLEUKIN 15 SIGNALING | 12 | 8.69e-01 | -0.027500 | 9.39e-01 |
PHASE 2 PLATEAU PHASE | 10 | 8.81e-01 | -0.027400 | 9.43e-01 |
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 8.33e-01 | 0.027200 | 9.26e-01 |
SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 8.55e-01 | -0.026400 | 9.35e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 8.69e-01 | 0.026400 | 9.39e-01 |
P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 8.70e-01 | -0.026200 | 9.39e-01 |
MRNA SPLICING MINOR PATHWAY | 52 | 7.44e-01 | -0.026200 | 8.80e-01 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 66 | 7.15e-01 | -0.026000 | 8.55e-01 |
SHC MEDIATED CASCADE FGFR3 | 13 | 8.72e-01 | -0.025800 | 9.39e-01 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 14 | 8.68e-01 | -0.025700 | 9.39e-01 |
P75NTR SIGNALS VIA NF KB | 16 | 8.59e-01 | -0.025600 | 9.36e-01 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 7.65e-01 | 0.025500 | 8.87e-01 |
NGF STIMULATED TRANSCRIPTION | 36 | 7.92e-01 | 0.025500 | 9.01e-01 |
SIGNALING BY ERBB2 IN CANCER | 25 | 8.26e-01 | 0.025400 | 9.21e-01 |
G PROTEIN BETA GAMMA SIGNALLING | 31 | 8.13e-01 | 0.024600 | 9.15e-01 |
IRAK1 RECRUITS IKK COMPLEX | 14 | 8.74e-01 | 0.024400 | 9.39e-01 |
MET ACTIVATES PTK2 SIGNALING | 29 | 8.21e-01 | 0.024300 | 9.19e-01 |
DEGRADATION OF AXIN | 53 | 7.61e-01 | 0.024200 | 8.86e-01 |
MRNA CAPPING | 29 | 8.24e-01 | 0.023900 | 9.21e-01 |
NONHOMOLOGOUS END JOINING NHEJ | 46 | 7.81e-01 | -0.023700 | 8.94e-01 |
RHO GTPASES ACTIVATE PAKS | 21 | 8.51e-01 | -0.023700 | 9.35e-01 |
DNA DOUBLE STRAND BREAK REPAIR | 140 | 6.42e-01 | -0.022800 | 8.03e-01 |
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 5.51e-01 | -0.022500 | 7.35e-01 |
DEADENYLATION DEPENDENT MRNA DECAY | 55 | 7.78e-01 | 0.021900 | 8.94e-01 |
AGGREPHAGY | 34 | 8.26e-01 | 0.021900 | 9.21e-01 |
INTERLEUKIN 12 FAMILY SIGNALING | 43 | 8.08e-01 | 0.021400 | 9.14e-01 |
ORC1 REMOVAL FROM CHROMATIN | 67 | 7.62e-01 | 0.021400 | 8.86e-01 |
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 78 | 7.44e-01 | 0.021400 | 8.80e-01 |
SENSORY PROCESSING OF SOUND | 62 | 7.74e-01 | -0.021100 | 8.92e-01 |
DEVELOPMENTAL BIOLOGY | 831 | 3.20e-01 | -0.020400 | 5.58e-01 |
TRANSCRIPTIONAL REGULATION BY MECP2 | 59 | 7.91e-01 | -0.019900 | 9.01e-01 |
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 20 | 8.78e-01 | 0.019900 | 9.42e-01 |
RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 8.14e-01 | 0.019800 | 9.16e-01 |
SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 41 | 8.26e-01 | 0.019800 | 9.21e-01 |
INTERLEUKIN 12 SIGNALING | 37 | 8.36e-01 | 0.019600 | 9.27e-01 |
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 20 | 8.80e-01 | 0.019500 | 9.43e-01 |
NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 8.36e-01 | -0.019400 | 9.27e-01 |
DAP12 INTERACTIONS | 30 | 8.55e-01 | -0.019300 | 9.35e-01 |
REGULATION OF BETA CELL DEVELOPMENT | 30 | 8.56e-01 | -0.019100 | 9.36e-01 |
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 96 | 7.49e-01 | -0.018900 | 8.80e-01 |
ANTIGEN PROCESSING CROSS PRESENTATION | 97 | 7.48e-01 | -0.018900 | 8.80e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 20 | 8.86e-01 | -0.018600 | 9.48e-01 |
GENERATION OF SECOND MESSENGER MOLECULES | 19 | 8.89e-01 | -0.018500 | 9.50e-01 |
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 74 | 7.86e-01 | 0.018200 | 8.99e-01 |
THE NLRP3 INFLAMMASOME | 15 | 9.04e-01 | 0.018000 | 9.61e-01 |
DEGRADATION OF DVL | 55 | 8.20e-01 | -0.017700 | 9.19e-01 |
SIGNALING BY CSF3 G CSF | 29 | 8.70e-01 | 0.017500 | 9.39e-01 |
FRS MEDIATED FGFR1 SIGNALING | 18 | 8.98e-01 | -0.017500 | 9.56e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX2 | 108 | 7.54e-01 | -0.017400 | 8.84e-01 |
FLT3 SIGNALING IN DISEASE | 28 | 8.74e-01 | 0.017300 | 9.39e-01 |
ORGANIC CATION ANION ZWITTERION TRANSPORT | 11 | 9.22e-01 | -0.017000 | 9.72e-01 |
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 68 | 8.11e-01 | -0.016800 | 9.15e-01 |
RA BIOSYNTHESIS PATHWAY | 13 | 9.18e-01 | -0.016600 | 9.69e-01 |
SIGNALING BY ERYTHROPOIETIN | 24 | 8.88e-01 | 0.016600 | 9.49e-01 |
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 70 | 8.13e-01 | 0.016400 | 9.15e-01 |
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 9.04e-01 | -0.016400 | 9.61e-01 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 9.25e-01 | 0.016300 | 9.74e-01 |
EXTRACELLULAR MATRIX ORGANIZATION | 251 | 6.63e-01 | -0.016000 | 8.19e-01 |
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 78 | 8.07e-01 | 0.016000 | 9.14e-01 |
SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 8.59e-01 | -0.015800 | 9.36e-01 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 8.46e-01 | -0.015400 | 9.31e-01 |
HIV TRANSCRIPTION INITIATION | 45 | 8.58e-01 | 0.015400 | 9.36e-01 |
ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 62 | 8.38e-01 | 0.015000 | 9.27e-01 |
TRANSCRIPTIONAL REGULATION BY TP53 | 343 | 6.40e-01 | 0.014700 | 8.02e-01 |
SEMAPHORIN INTERACTIONS | 64 | 8.39e-01 | -0.014700 | 9.27e-01 |
DAP12 SIGNALING | 24 | 9.02e-01 | -0.014500 | 9.60e-01 |
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 46 | 8.66e-01 | -0.014400 | 9.39e-01 |
DOWNREGULATION OF ERBB2 SIGNALING | 28 | 8.96e-01 | 0.014300 | 9.56e-01 |
G2 M CHECKPOINTS | 136 | 7.75e-01 | -0.014200 | 8.93e-01 |
TRAF6 MEDIATED NF KB ACTIVATION | 22 | 9.09e-01 | -0.014100 | 9.63e-01 |
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 17 | 9.21e-01 | -0.013900 | 9.72e-01 |
DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 51 | 8.66e-01 | -0.013600 | 9.39e-01 |
SIGNALING BY FGFR | 75 | 8.43e-01 | 0.013200 | 9.29e-01 |
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 9.39e-01 | 0.012700 | 9.76e-01 |
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 9.11e-01 | 0.012600 | 9.64e-01 |
ENDOGENOUS STEROLS | 20 | 9.24e-01 | 0.012400 | 9.73e-01 |
JOSEPHIN DOMAIN DUBS | 11 | 9.46e-01 | 0.011800 | 9.76e-01 |
MAPK6 MAPK4 SIGNALING | 83 | 8.53e-01 | -0.011800 | 9.35e-01 |
PI 3K CASCADE FGFR4 | 13 | 9.42e-01 | 0.011600 | 9.76e-01 |
NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 11 | 9.48e-01 | -0.011400 | 9.76e-01 |
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 23 | 9.27e-01 | 0.011000 | 9.74e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 37 | 9.08e-01 | -0.010900 | 9.63e-01 |
DNA REPAIR | 295 | 7.56e-01 | -0.010500 | 8.85e-01 |
N GLYCAN ANTENNAE ELONGATION | 15 | 9.45e-01 | 0.010300 | 9.76e-01 |
HEME SIGNALING | 46 | 9.06e-01 | -0.010100 | 9.61e-01 |
SIGNALING BY NOTCH4 | 83 | 8.74e-01 | 0.010100 | 9.39e-01 |
G BETA GAMMA SIGNALLING THROUGH CDC42 | 19 | 9.40e-01 | 0.009930 | 9.76e-01 |
ESR MEDIATED SIGNALING | 171 | 8.24e-01 | -0.009870 | 9.21e-01 |
SIGNALING BY NODAL | 15 | 9.50e-01 | 0.009360 | 9.77e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 9.44e-01 | 0.009260 | 9.76e-01 |
NERVOUS SYSTEM DEVELOPMENT | 553 | 7.16e-01 | -0.009080 | 8.55e-01 |
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 21 | 9.43e-01 | 0.008980 | 9.76e-01 |
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 9.42e-01 | 0.008840 | 9.76e-01 |
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 29 | 9.35e-01 | -0.008720 | 9.76e-01 |
CELLULAR RESPONSES TO EXTERNAL STIMULI | 606 | 7.19e-01 | -0.008580 | 8.57e-01 |
PROCESSING OF INTRONLESS PRE MRNAS | 19 | 9.48e-01 | 0.008570 | 9.76e-01 |
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 9.61e-01 | -0.008550 | 9.80e-01 |
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 29 | 9.37e-01 | -0.008520 | 9.76e-01 |
PERK REGULATES GENE EXPRESSION | 28 | 9.39e-01 | -0.008380 | 9.76e-01 |
FANCONI ANEMIA PATHWAY | 36 | 9.33e-01 | 0.008140 | 9.76e-01 |
CELLULAR SENESCENCE | 144 | 8.68e-01 | 0.008050 | 9.39e-01 |
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 9.30e-01 | 0.007960 | 9.76e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX3 | 94 | 8.97e-01 | 0.007760 | 9.56e-01 |
METALLOPROTEASE DUBS | 26 | 9.48e-01 | -0.007340 | 9.76e-01 |
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 179 | 8.67e-01 | 0.007280 | 9.39e-01 |
DNA DAMAGE BYPASS | 47 | 9.31e-01 | -0.007270 | 9.76e-01 |
STABILIZATION OF P53 | 54 | 9.27e-01 | -0.007250 | 9.74e-01 |
POLO LIKE KINASE MEDIATED EVENTS | 14 | 9.63e-01 | -0.007170 | 9.80e-01 |
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 9.47e-01 | 0.007010 | 9.76e-01 |
TELOMERE EXTENSION BY TELOMERASE | 22 | 9.55e-01 | -0.006880 | 9.79e-01 |
SIGNALING BY NOTCH | 192 | 8.73e-01 | 0.006710 | 9.39e-01 |
SURFACTANT METABOLISM | 16 | 9.63e-01 | 0.006700 | 9.80e-01 |
ANTIMICROBIAL PEPTIDES | 16 | 9.64e-01 | -0.006450 | 9.81e-01 |
MITOCHONDRIAL BIOGENESIS | 92 | 9.16e-01 | 0.006360 | 9.69e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 26 | 9.56e-01 | -0.006320 | 9.79e-01 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 60 | 9.42e-01 | -0.005470 | 9.76e-01 |
ROS AND RNS PRODUCTION IN PHAGOCYTES | 29 | 9.61e-01 | -0.005240 | 9.80e-01 |
FOXO MEDIATED TRANSCRIPTION | 57 | 9.48e-01 | -0.005000 | 9.76e-01 |
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 23 | 9.67e-01 | -0.004980 | 9.82e-01 |
SYNDECAN INTERACTIONS | 27 | 9.66e-01 | 0.004800 | 9.81e-01 |
RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 9.44e-01 | -0.004750 | 9.76e-01 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 9.53e-01 | -0.004660 | 9.78e-01 |
SIGNALING BY FGFR2 | 63 | 9.49e-01 | 0.004650 | 9.76e-01 |
CELLULAR RESPONSE TO HYPOXIA | 72 | 9.48e-01 | -0.004430 | 9.76e-01 |
DUAL INCISION IN GG NER | 41 | 9.61e-01 | -0.004380 | 9.80e-01 |
NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 9.68e-01 | -0.004330 | 9.82e-01 |
NUCLEOTIDE EXCISION REPAIR | 110 | 9.41e-01 | 0.004070 | 9.76e-01 |
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 9.74e-01 | 0.003990 | 9.85e-01 |
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 9.79e-01 | 0.003970 | 9.87e-01 |
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 85 | 9.53e-01 | -0.003680 | 9.78e-01 |
APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 9.79e-01 | -0.003620 | 9.87e-01 |
OTHER INTERLEUKIN SIGNALING | 20 | 9.78e-01 | 0.003500 | 9.87e-01 |
TRANSCRIPTION OF THE HIV GENOME | 67 | 9.61e-01 | 0.003430 | 9.80e-01 |
CHAPERONE MEDIATED AUTOPHAGY | 20 | 9.80e-01 | -0.003300 | 9.87e-01 |
ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY | 10 | 9.86e-01 | -0.003100 | 9.92e-01 |
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 59 | 9.69e-01 | 0.002950 | 9.82e-01 |
PEPTIDE LIGAND BINDING RECEPTORS | 112 | 9.61e-01 | 0.002710 | 9.80e-01 |
SIGNALING BY FGFR IN DISEASE | 57 | 9.79e-01 | -0.002010 | 9.87e-01 |
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 9.91e-01 | 0.001650 | 9.95e-01 |
HATS ACETYLATE HISTONES | 96 | 9.83e-01 | 0.001290 | 9.89e-01 |
SIGNALING BY PDGF | 56 | 9.87e-01 | -0.001250 | 9.92e-01 |
RNA POLYMERASE II TRANSCRIPTION | 1098 | 9.73e-01 | 0.000604 | 9.85e-01 |
BETA CATENIN INDEPENDENT WNT SIGNALING | 140 | 9.92e-01 | 0.000471 | 9.96e-01 |
AURKA ACTIVATION BY TPX2 | 71 | 9.95e-01 | 0.000398 | 9.98e-01 |
ARACHIDONIC ACID METABOLISM | 39 | 9.97e-01 | 0.000323 | 9.99e-01 |
HS GAG DEGRADATION | 20 | 9.99e-01 | -0.000233 | 9.99e-01 |
MUSCLE CONTRACTION | 160 | 9.98e-01 | -0.000098 | 9.99e-01 |
CITRIC ACID CYCLE TCA CYCLE
154 | |
---|---|
set | CITRIC ACID CYCLE TCA CYCLE |
setSize | 22 |
pANOVA | 3.44e-05 |
s.dist | 0.51 |
p.adjustANOVA | 0.000941 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fh1 | 9133 |
Idh3a | 8827 |
Dld | 8678 |
Suclg2 | 8614 |
Aco2 | 8602 |
Idh2 | 8064 |
Sucla2 | 7808 |
Idh3b | 7713 |
Sdha | 6929 |
Dlst | 6267 |
Me2 | 6249 |
Cs | 5426 |
Sdhd | 5004 |
Idh3g | 5001 |
Ogdh | 4675 |
Nnt | 3267 |
Mdh2 | 2250 |
Sdhb | 1649 |
Sdhc | 1351 |
Suclg1 | 982 |
GeneID | Gene Rank |
---|---|
Fh1 | 9133 |
Idh3a | 8827 |
Dld | 8678 |
Suclg2 | 8614 |
Aco2 | 8602 |
Idh2 | 8064 |
Sucla2 | 7808 |
Idh3b | 7713 |
Sdha | 6929 |
Dlst | 6267 |
Me2 | 6249 |
Cs | 5426 |
Sdhd | 5004 |
Idh3g | 5001 |
Ogdh | 4675 |
Nnt | 3267 |
Mdh2 | 2250 |
Sdhb | 1649 |
Sdhc | 1351 |
Suclg1 | 982 |
Me3 | -990 |
Fahd1 | -4036 |
OLFACTORY SIGNALING PATHWAY
663 | |
---|---|
set | OLFACTORY SIGNALING PATHWAY |
setSize | 37 |
pANOVA | 1.51e-07 |
s.dist | -0.499 |
p.adjustANOVA | 1.11e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Olfr981 | -8240 |
Olfr1310 | -8239 |
Olfr354 | -8223 |
Olfr1192-ps1 | -8078 |
Olfr90 | -7978 |
Olfr635 | -7971 |
Olfr1309 | -7846 |
Olfr986 | -7571 |
Gng13 | -7562 |
Olfr1385 | -7541 |
Olfr804 | -7478 |
Olfr161 | -7379 |
Olfr365 | -7362 |
Olfr558 | -7277 |
Olfr796 | -7245 |
Olfr63 | -7101 |
Olfr1507 | -6904 |
Olfr78 | -6875 |
Olfr1564 | -6546 |
Olfr2 | -5832 |
GeneID | Gene Rank |
---|---|
Olfr981 | -8240 |
Olfr1310 | -8239 |
Olfr354 | -8223 |
Olfr1192-ps1 | -8078 |
Olfr90 | -7978 |
Olfr635 | -7971 |
Olfr1309 | -7846 |
Olfr986 | -7571 |
Gng13 | -7562 |
Olfr1385 | -7541 |
Olfr804 | -7478 |
Olfr161 | -7379 |
Olfr365 | -7362 |
Olfr558 | -7277 |
Olfr796 | -7245 |
Olfr63 | -7101 |
Olfr1507 | -6904 |
Olfr78 | -6875 |
Olfr1564 | -6546 |
Olfr2 | -5832 |
Olfr735 | -5804 |
Olfr31 | -5445 |
Rtp4 | -5038 |
Olfr147 | -3047 |
Olfr95 | -2964 |
Olfr552 | -1382 |
Olfr137 | -1240 |
Reep4 | -272 |
Reep6 | -269 |
Olfr287 | 473 |
Olfr648 | 1879 |
Reep2 | 3136 |
Gnal | 4031 |
Gnb1 | 4895 |
Reep3 | 5314 |
Reep5 | 6599 |
Reep1 | 7064 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE
1046 | |
---|---|
set | SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE |
setSize | 11 |
pANOVA | 0.0042 |
s.dist | 0.498 |
p.adjustANOVA | 0.033 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fig4 | 9255 |
Pik3c3 | 6958 |
Pik3c2a | 6871 |
Pik3r4 | 6218 |
Mtmr2 | 6064 |
Vac14 | 5945 |
Mtm1 | 5796 |
Mtmr7 | 5163 |
Mtmr4 | 4824 |
Mtmr9 | -1103 |
Pikfyve | -1363 |
GeneID | Gene Rank |
---|---|
Fig4 | 9255 |
Pik3c3 | 6958 |
Pik3c2a | 6871 |
Pik3r4 | 6218 |
Mtmr2 | 6064 |
Vac14 | 5945 |
Mtm1 | 5796 |
Mtmr7 | 5163 |
Mtmr4 | 4824 |
Mtmr9 | -1103 |
Pikfyve | -1363 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM
47 | |
---|---|
set | ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM |
setSize | 12 |
pANOVA | 0.00304 |
s.dist | 0.494 |
p.adjustANOVA | 0.0258 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hsd17b4 | 8978 |
Elovl2 | 8860 |
Acox1 | 8768 |
Fads2 | 8555 |
Acsl1 | 7586 |
Fads1 | 7236 |
Elovl1 | 6340 |
Elovl5 | 6153 |
Scp2 | 4295 |
Acaa1a | -518 |
Acot8 | -2870 |
Abcd1 | -4259 |
GeneID | Gene Rank |
---|---|
Hsd17b4 | 8978 |
Elovl2 | 8860 |
Acox1 | 8768 |
Fads2 | 8555 |
Acsl1 | 7586 |
Fads1 | 7236 |
Elovl1 | 6340 |
Elovl5 | 6153 |
Scp2 | 4295 |
Acaa1a | -518 |
Acot8 | -2870 |
Abcd1 | -4259 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS
757 | |
---|---|
set | PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS |
setSize | 12 |
pANOVA | 0.00362 |
s.dist | 0.485 |
p.adjustANOVA | 0.0296 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Paics | 9163 |
Atic | 7987 |
Adsl | 7826 |
Gart | 7723 |
Adss | 6791 |
Impdh2 | 6200 |
Ppat | 5022 |
Impdh1 | 3875 |
Gmps | 3087 |
Lhpp | 2720 |
Adssl1 | 2686 |
Pfas | -4910 |
GeneID | Gene Rank |
---|---|
Paics | 9163 |
Atic | 7987 |
Adsl | 7826 |
Gart | 7723 |
Adss | 6791 |
Impdh2 | 6200 |
Ppat | 5022 |
Impdh1 | 3875 |
Gmps | 3087 |
Lhpp | 2720 |
Adssl1 | 2686 |
Pfas | -4910 |
CALNEXIN CALRETICULIN CYCLE
110 | |
---|---|
set | CALNEXIN CALRETICULIN CYCLE |
setSize | 26 |
pANOVA | 2.35e-05 |
s.dist | 0.479 |
p.adjustANOVA | 0.000768 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Edem2 | 9300 |
Derl2 | 9261 |
Ganab | 9006 |
Man1b1 | 8695 |
Pdia3 | 8431 |
Syvn1 | 8025 |
Amfr | 7876 |
Uggt1 | 7856 |
Os9 | 7744 |
Rnf139 | 7183 |
Marchf6 | 7065 |
Edem3 | 6523 |
Ubc | 5932 |
Edem1 | 5389 |
Calr | 5198 |
Sel1l | 5080 |
Rnf103 | 5033 |
Trim13 | 4178 |
Uggt2 | 3860 |
Rnf185 | 2134 |
GeneID | Gene Rank |
---|---|
Edem2 | 9300 |
Derl2 | 9261 |
Ganab | 9006 |
Man1b1 | 8695 |
Pdia3 | 8431 |
Syvn1 | 8025 |
Amfr | 7876 |
Uggt1 | 7856 |
Os9 | 7744 |
Rnf139 | 7183 |
Marchf6 | 7065 |
Edem3 | 6523 |
Ubc | 5932 |
Edem1 | 5389 |
Calr | 5198 |
Sel1l | 5080 |
Rnf103 | 5033 |
Trim13 | 4178 |
Uggt2 | 3860 |
Rnf185 | 2134 |
Canx | 1752 |
Rnf5 | 1025 |
Prkcsh | 96 |
Rps27a | -2071 |
Ubb | -2115 |
Uba52 | -7859 |
ER QUALITY CONTROL COMPARTMENT ERQC
293 | |
---|---|
set | ER QUALITY CONTROL COMPARTMENT ERQC |
setSize | 21 |
pANOVA | 0.000158 |
s.dist | 0.476 |
p.adjustANOVA | 0.00298 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Edem2 | 9300 |
Derl2 | 9261 |
Man1b1 | 8695 |
Syvn1 | 8025 |
Amfr | 7876 |
Uggt1 | 7856 |
Os9 | 7744 |
Rnf139 | 7183 |
Marchf6 | 7065 |
Edem3 | 6523 |
Ubc | 5932 |
Edem1 | 5389 |
Sel1l | 5080 |
Rnf103 | 5033 |
Trim13 | 4178 |
Uggt2 | 3860 |
Rnf185 | 2134 |
Rnf5 | 1025 |
Rps27a | -2071 |
Ubb | -2115 |
GeneID | Gene Rank |
---|---|
Edem2 | 9300 |
Derl2 | 9261 |
Man1b1 | 8695 |
Syvn1 | 8025 |
Amfr | 7876 |
Uggt1 | 7856 |
Os9 | 7744 |
Rnf139 | 7183 |
Marchf6 | 7065 |
Edem3 | 6523 |
Ubc | 5932 |
Edem1 | 5389 |
Sel1l | 5080 |
Rnf103 | 5033 |
Trim13 | 4178 |
Uggt2 | 3860 |
Rnf185 | 2134 |
Rnf5 | 1025 |
Rps27a | -2071 |
Ubb | -2115 |
Uba52 | -7859 |
RHOBTB3 ATPASE CYCLE
860 | |
---|---|
set | RHOBTB3 ATPASE CYCLE |
setSize | 10 |
pANOVA | 0.00936 |
s.dist | 0.475 |
p.adjustANOVA | 0.0582 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Htr7 | 9100 |
Cul3 | 8203 |
Lrrc41 | 7885 |
Plin3 | 6740 |
Rhobtb3 | 6730 |
Hgs | 5861 |
Rab9b | 4398 |
Vhl | 2581 |
Rab9 | -1262 |
Ccne1 | -2675 |
GeneID | Gene Rank |
---|---|
Htr7 | 9100 |
Cul3 | 8203 |
Lrrc41 | 7885 |
Plin3 | 6740 |
Rhobtb3 | 6730 |
Hgs | 5861 |
Rab9b | 4398 |
Vhl | 2581 |
Rab9 | -1262 |
Ccne1 | -2675 |
BRANCHED CHAIN AMINO ACID CATABOLISM
104 | |
---|---|
set | BRANCHED CHAIN AMINO ACID CATABOLISM |
setSize | 21 |
pANOVA | 0.000192 |
s.dist | 0.47 |
p.adjustANOVA | 0.00337 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Aldh6a1 | 9266 |
Ivd | 8736 |
Dld | 8678 |
Echs1 | 8363 |
Acat1 | 8250 |
Hibadh | 8043 |
Dbt | 7239 |
Acad8 | 7102 |
Slc25a44 | 6765 |
Acadsb | 6761 |
Bcat2 | 6689 |
Bckdhb | 6648 |
Mccc2 | 5898 |
Mccc1 | 5344 |
Hsd17b10 | 3221 |
Bcat1 | 2399 |
Hibch | -65 |
Bckdk | -1049 |
Bckdha | -1160 |
Auh | -1850 |
GeneID | Gene Rank |
---|---|
Aldh6a1 | 9266 |
Ivd | 8736 |
Dld | 8678 |
Echs1 | 8363 |
Acat1 | 8250 |
Hibadh | 8043 |
Dbt | 7239 |
Acad8 | 7102 |
Slc25a44 | 6765 |
Acadsb | 6761 |
Bcat2 | 6689 |
Bckdhb | 6648 |
Mccc2 | 5898 |
Mccc1 | 5344 |
Hsd17b10 | 3221 |
Bcat1 | 2399 |
Hibch | -65 |
Bckdk | -1049 |
Bckdha | -1160 |
Auh | -1850 |
Ppm1k | -6285 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE
1044 | |
---|---|
set | SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE |
setSize | 16 |
pANOVA | 0.00114 |
s.dist | 0.47 |
p.adjustANOVA | 0.0127 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fig4 | 9255 |
Mtmr10 | 8910 |
Inpp5f | 7618 |
Pi4k2a | 7273 |
Pik3c3 | 6958 |
Pik3c2a | 6871 |
Pik3r4 | 6218 |
Mtmr2 | 6064 |
Vac14 | 5945 |
Mtm1 | 5796 |
Inpp4b | 5661 |
Mtmr4 | 4824 |
Mtmr12 | 2421 |
Pikfyve | -1363 |
Pi4k2b | -2260 |
Inpp4a | -4795 |
GeneID | Gene Rank |
---|---|
Fig4 | 9255 |
Mtmr10 | 8910 |
Inpp5f | 7618 |
Pi4k2a | 7273 |
Pik3c3 | 6958 |
Pik3c2a | 6871 |
Pik3r4 | 6218 |
Mtmr2 | 6064 |
Vac14 | 5945 |
Mtm1 | 5796 |
Inpp4b | 5661 |
Mtmr4 | 4824 |
Mtmr12 | 2421 |
Pikfyve | -1363 |
Pi4k2b | -2260 |
Inpp4a | -4795 |
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1
448 | |
---|---|
set | INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 |
setSize | 13 |
pANOVA | 0.00398 |
s.dist | 0.461 |
p.adjustANOVA | 0.0317 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Prim2 | 8549 |
E2f1 | 8530 |
Tfdp1 | 8407 |
Prim1 | 7456 |
Rb1 | 7232 |
Pola2 | 7148 |
Pola1 | 5712 |
Ppp2ca | 5171 |
Ppp2r1a | 4643 |
Ppp2r1b | 3997 |
Tfdp2 | 950 |
Ppp2cb | -1872 |
Ppp2r3d | -5628 |
GeneID | Gene Rank |
---|---|
Prim2 | 8549 |
E2f1 | 8530 |
Tfdp1 | 8407 |
Prim1 | 7456 |
Rb1 | 7232 |
Pola2 | 7148 |
Pola1 | 5712 |
Ppp2ca | 5171 |
Ppp2r1a | 4643 |
Ppp2r1b | 3997 |
Tfdp2 | 950 |
Ppp2cb | -1872 |
Ppp2r3d | -5628 |
ASPARTATE AND ASPARAGINE METABOLISM
74 | |
---|---|
set | ASPARTATE AND ASPARAGINE METABOLISM |
setSize | 10 |
pANOVA | 0.0125 |
s.dist | 0.456 |
p.adjustANOVA | 0.0713 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Folh1 | 9329 |
Asns | 7860 |
Slc25a12 | 7310 |
Aspa | 6690 |
Got1 | 6414 |
Got2 | 5975 |
Slc25a13 | 2805 |
Aspg | 1022 |
Nat8l | -149 |
Naalad2 | -1305 |
GeneID | Gene Rank |
---|---|
Folh1 | 9329 |
Asns | 7860 |
Slc25a12 | 7310 |
Aspa | 6690 |
Got1 | 6414 |
Got2 | 5975 |
Slc25a13 | 2805 |
Aspg | 1022 |
Nat8l | -149 |
Naalad2 | -1305 |
MET ACTIVATES RAP1 AND RAC1
539 | |
---|---|
set | MET ACTIVATES RAP1 AND RAC1 |
setSize | 10 |
pANOVA | 0.0133 |
s.dist | 0.452 |
p.adjustANOVA | 0.0732 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rac1 | 8591 |
Rap1b | 7791 |
Crkl | 7397 |
Crk | 6793 |
Gab1 | 6014 |
Rap1a | 5148 |
Met | 3935 |
Rapgef1 | 3784 |
Grb2 | -1885 |
Dock7 | -1969 |
GeneID | Gene Rank |
---|---|
Rac1 | 8591 |
Rap1b | 7791 |
Crkl | 7397 |
Crk | 6793 |
Gab1 | 6014 |
Rap1a | 5148 |
Met | 3935 |
Rapgef1 | 3784 |
Grb2 | -1885 |
Dock7 | -1969 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM
92 | |
---|---|
set | BBSOME MEDIATED CARGO TARGETING TO CILIUM |
setSize | 23 |
pANOVA | 0.000175 |
s.dist | 0.452 |
p.adjustANOVA | 0.00321 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Lztfl1 | 8991 |
Tcp1 | 8148 |
Mchr1 | 7425 |
Arl6 | 7411 |
Mkks | 7250 |
Bbs1 | 7110 |
Rab3ip | 7096 |
Cct3 | 6618 |
Bbs7 | 6425 |
Cct5 | 6045 |
Ttc8 | 5746 |
Bbs10 | 5621 |
Bbs4 | 5540 |
Cct4 | 5520 |
Smo | 5122 |
Cct2 | 3787 |
Sstr3 | 3325 |
Cct8 | 3153 |
Bbs2 | 306 |
Bbs12 | -115 |
GeneID | Gene Rank |
---|---|
Lztfl1 | 8991 |
Tcp1 | 8148 |
Mchr1 | 7425 |
Arl6 | 7411 |
Mkks | 7250 |
Bbs1 | 7110 |
Rab3ip | 7096 |
Cct3 | 6618 |
Bbs7 | 6425 |
Cct5 | 6045 |
Ttc8 | 5746 |
Bbs10 | 5621 |
Bbs4 | 5540 |
Cct4 | 5520 |
Smo | 5122 |
Cct2 | 3787 |
Sstr3 | 3325 |
Cct8 | 3153 |
Bbs2 | 306 |
Bbs12 | -115 |
Bbs9 | -196 |
Bbip1 | -690 |
Bbs5 | -4881 |
RETROGRADE NEUROTROPHIN SIGNALLING
842 | |
---|---|
set | RETROGRADE NEUROTROPHIN SIGNALLING |
setSize | 14 |
pANOVA | 0.00482 |
s.dist | 0.435 |
p.adjustANOVA | 0.0364 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Dnm2 | 9347 |
Ap2b1 | 7444 |
Ap2a2 | 7134 |
Ntrk1 | 6899 |
Cltc | 6291 |
Dnm3 | 6028 |
Ngf | 5435 |
Dnm1 | 4326 |
Ap2m1 | 4122 |
Ap2a1 | 3883 |
Sh3gl2 | 3298 |
Dnal4 | 1863 |
Clta | -54 |
Ap2s1 | -4313 |
GeneID | Gene Rank |
---|---|
Dnm2 | 9347 |
Ap2b1 | 7444 |
Ap2a2 | 7134 |
Ntrk1 | 6899 |
Cltc | 6291 |
Dnm3 | 6028 |
Ngf | 5435 |
Dnm1 | 4326 |
Ap2m1 | 4122 |
Ap2a1 | 3883 |
Sh3gl2 | 3298 |
Dnal4 | 1863 |
Clta | -54 |
Ap2s1 | -4313 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB
111 | |
---|---|
set | CAMK IV MEDIATED PHOSPHORYLATION OF CREB |
setSize | 10 |
pANOVA | 0.0187 |
s.dist | 0.429 |
p.adjustANOVA | 0.0896 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Kpna2 | 9344 |
Creb1 | 8392 |
Camk2a | 7843 |
Camkk1 | 6095 |
Camk2g | 5543 |
Camk4 | 5130 |
Camk2d | 3322 |
Camk2b | 943 |
Camkk2 | 43 |
Calm1 | -3079 |
GeneID | Gene Rank |
---|---|
Kpna2 | 9344 |
Creb1 | 8392 |
Camk2a | 7843 |
Camkk1 | 6095 |
Camk2g | 5543 |
Camk4 | 5130 |
Camk2d | 3322 |
Camk2b | 943 |
Camkk2 | 43 |
Calm1 | -3079 |
SCAVENGING OF HEME FROM PLASMA
907 | |
---|---|
set | SCAVENGING OF HEME FROM PLASMA |
setSize | 11 |
pANOVA | 0.0144 |
s.dist | -0.426 |
p.adjustANOVA | 0.0761 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Apol7e | -6909 |
Hp | -6777 |
Apol9a | -6641 |
Hbb-bt | -5506 |
Hba-a1 | -5351 |
Jchain | -5032 |
Hba-a2 | -4252 |
Apoa1 | -2839 |
Apol8 | 1404 |
Lrp1 | 2282 |
Cd163 | 4594 |
GeneID | Gene Rank |
---|---|
Apol7e | -6909 |
Hp | -6777 |
Apol9a | -6641 |
Hbb-bt | -5506 |
Hba-a1 | -5351 |
Jchain | -5032 |
Hba-a2 | -4252 |
Apoa1 | -2839 |
Apol8 | 1404 |
Lrp1 | 2282 |
Cd163 | 4594 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS
1051 | |
---|---|
set | SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS |
setSize | 20 |
pANOVA | 0.000982 |
s.dist | 0.426 |
p.adjustANOVA | 0.0114 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Acsbg1 | 9232 |
Acsl3 | 8989 |
Elovl2 | 8860 |
Acsl6 | 8499 |
Hsd17b12 | 7925 |
Acsl1 | 7586 |
Acsl4 | 7378 |
Hacd2 | 7234 |
Hacd4 | 6744 |
Elovl4 | 6612 |
Elovl1 | 6340 |
Elovl5 | 6153 |
Acsf3 | 4043 |
Acsl5 | 3751 |
Elovl6 | 3694 |
Hacd3 | 1138 |
Slc27a3 | -2394 |
Tecr | -4047 |
Hacd1 | -5403 |
Elovl7 | -5881 |
GeneID | Gene Rank |
---|---|
Acsbg1 | 9232 |
Acsl3 | 8989 |
Elovl2 | 8860 |
Acsl6 | 8499 |
Hsd17b12 | 7925 |
Acsl1 | 7586 |
Acsl4 | 7378 |
Hacd2 | 7234 |
Hacd4 | 6744 |
Elovl4 | 6612 |
Elovl1 | 6340 |
Elovl5 | 6153 |
Acsf3 | 4043 |
Acsl5 | 3751 |
Elovl6 | 3694 |
Hacd3 | 1138 |
Slc27a3 | -2394 |
Tecr | -4047 |
Hacd1 | -5403 |
Elovl7 | -5881 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE
594 | |
---|---|
set | N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE |
setSize | 35 |
pANOVA | 1.56e-05 |
s.dist | 0.422 |
p.adjustANOVA | 0.000581 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Edem2 | 9300 |
Derl2 | 9261 |
Ganab | 9006 |
Man1b1 | 8695 |
Derl1 | 8460 |
Pdia3 | 8431 |
Mlec | 8086 |
Syvn1 | 8025 |
Ngly1 | 8020 |
Amfr | 7876 |
Uggt1 | 7856 |
Os9 | 7744 |
Rnf139 | 7183 |
Marchf6 | 7065 |
Edem3 | 6523 |
Ubc | 5932 |
Edem1 | 5389 |
Calr | 5198 |
Sel1l | 5080 |
Rnf103 | 5033 |
GeneID | Gene Rank |
---|---|
Edem2 | 9300 |
Derl2 | 9261 |
Ganab | 9006 |
Man1b1 | 8695 |
Derl1 | 8460 |
Pdia3 | 8431 |
Mlec | 8086 |
Syvn1 | 8025 |
Ngly1 | 8020 |
Amfr | 7876 |
Uggt1 | 7856 |
Os9 | 7744 |
Rnf139 | 7183 |
Marchf6 | 7065 |
Edem3 | 6523 |
Ubc | 5932 |
Edem1 | 5389 |
Calr | 5198 |
Sel1l | 5080 |
Rnf103 | 5033 |
Rad23b | 4886 |
Vcp | 4493 |
Trim13 | 4178 |
Uggt2 | 3860 |
Rnf185 | 2134 |
Canx | 1752 |
Rnf5 | 1025 |
Engase | 897 |
Prkcsh | 96 |
Rps27a | -2071 |
Ubb | -2115 |
Ubxn1 | -2534 |
Mogs | -2859 |
Psmc1 | -4016 |
Uba52 | -7859 |
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS
1073 | |
---|---|
set | THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS |
setSize | 27 |
pANOVA | 0.000188 |
s.dist | 0.415 |
p.adjustANOVA | 0.00335 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ap1m1 | 9091 |
Elmo1 | 8839 |
Pak2 | 8711 |
Fyn | 8650 |
Rac1 | 8591 |
Ap1b1 | 7973 |
H2-Q2 | 7969 |
Atp6v1h | 7606 |
Ap2b1 | 7444 |
Ap2a2 | 7134 |
Hck | 6758 |
Dock2 | 6604 |
Ap1m2 | 5627 |
Arf1 | 4881 |
Pacs1 | 4524 |
Ap2m1 | 4122 |
Ap2a1 | 3883 |
Ap1g1 | 3869 |
Ap1s1 | 3748 |
Ap1s2 | 2197 |
GeneID | Gene Rank |
---|---|
Ap1m1 | 9091 |
Elmo1 | 8839 |
Pak2 | 8711 |
Fyn | 8650 |
Rac1 | 8591 |
Ap1b1 | 7973 |
H2-Q2 | 7969 |
Atp6v1h | 7606 |
Ap2b1 | 7444 |
Ap2a2 | 7134 |
Hck | 6758 |
Dock2 | 6604 |
Ap1m2 | 5627 |
Arf1 | 4881 |
Pacs1 | 4524 |
Ap2m1 | 4122 |
Ap2a1 | 3883 |
Ap1g1 | 3869 |
Ap1s1 | 3748 |
Ap1s2 | 2197 |
Lck | 1852 |
H2-Q7 | 40 |
B2m | -114 |
H2-D1 | -2015 |
H2-Q10 | -2381 |
Ap2s1 | -4313 |
Ap1s3 | -7097 |
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION
728 | |
---|---|
set | POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION |
setSize | 26 |
pANOVA | 0.000313 |
s.dist | 0.408 |
p.adjustANOVA | 0.0046 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Nup54 | 8879 |
Ndc1 | 8176 |
Rcc1 | 7498 |
Nup160 | 7385 |
Tnpo1 | 7074 |
Nup107 | 6351 |
Nup205 | 6182 |
Pom121 | 5822 |
Nup133 | 5734 |
Nup37 | 5696 |
Sec13 | 5690 |
Kpnb1 | 5613 |
Seh1l | 4719 |
Nup85 | 4516 |
Ahctf1 | 4490 |
Ube2i | 4393 |
Nup188 | 3203 |
Sumo1 | 2910 |
Ran | 2863 |
Rangap1 | 2273 |
GeneID | Gene Rank |
---|---|
Nup54 | 8879 |
Ndc1 | 8176 |
Rcc1 | 7498 |
Nup160 | 7385 |
Tnpo1 | 7074 |
Nup107 | 6351 |
Nup205 | 6182 |
Pom121 | 5822 |
Nup133 | 5734 |
Nup37 | 5696 |
Sec13 | 5690 |
Kpnb1 | 5613 |
Seh1l | 4719 |
Nup85 | 4516 |
Ahctf1 | 4490 |
Ube2i | 4393 |
Nup188 | 3203 |
Sumo1 | 2910 |
Ran | 2863 |
Rangap1 | 2273 |
Nup98 | 2184 |
Nup35 | 1611 |
Nup43 | 1247 |
Nup93 | -1282 |
Nup62 | -1905 |
Nup155 | -2921 |
CARNITINE METABOLISM
117 | |
---|---|
set | CARNITINE METABOLISM |
setSize | 14 |
pANOVA | 0.00834 |
s.dist | 0.407 |
p.adjustANOVA | 0.0535 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cpt1a | 8349 |
Prkag2 | 7700 |
Cpt2 | 7512 |
Rxra | 7494 |
Prkaa2 | 7318 |
Cpt1b | 6931 |
Mid1ip1 | 6514 |
Acacb | 4802 |
Acaca | 3651 |
Ppard | 2869 |
Slc25a20 | 2357 |
Thrsp | 18 |
Prkab2 | -699 |
Slc22a5 | -6559 |
GeneID | Gene Rank |
---|---|
Cpt1a | 8349 |
Prkag2 | 7700 |
Cpt2 | 7512 |
Rxra | 7494 |
Prkaa2 | 7318 |
Cpt1b | 6931 |
Mid1ip1 | 6514 |
Acacb | 4802 |
Acaca | 3651 |
Ppard | 2869 |
Slc25a20 | 2357 |
Thrsp | 18 |
Prkab2 | -699 |
Slc22a5 | -6559 |
ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS
8 | |
---|---|
set | ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS |
setSize | 10 |
pANOVA | 0.026 |
s.dist | 0.407 |
p.adjustANOVA | 0.111 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Chrna3 | 9155 |
Chrna4 | 7286 |
Chrna6 | 6848 |
Chrna5 | 6009 |
Chrnb4 | 5457 |
Chrnb2 | 4195 |
Chrnb3 | 2106 |
Chrna2 | 1054 |
Chrna7 | 1 |
Chrna1 | -542 |
GeneID | Gene Rank |
---|---|
Chrna3 | 9155 |
Chrna4 | 7286 |
Chrna6 | 6848 |
Chrna5 | 6009 |
Chrnb4 | 5457 |
Chrnb2 | 4195 |
Chrnb3 | 2106 |
Chrna2 | 1054 |
Chrna7 | 1 |
Chrna1 | -542 |
HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS
422 | |
---|---|
set | HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS |
setSize | 10 |
pANOVA | 0.026 |
s.dist | 0.407 |
p.adjustANOVA | 0.111 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Chrna3 | 9155 |
Chrna4 | 7286 |
Chrna6 | 6848 |
Chrna5 | 6009 |
Chrnb4 | 5457 |
Chrnb2 | 4195 |
Chrnb3 | 2106 |
Chrna2 | 1054 |
Chrna7 | 1 |
Chrna1 | -542 |
GeneID | Gene Rank |
---|---|
Chrna3 | 9155 |
Chrna4 | 7286 |
Chrna6 | 6848 |
Chrna5 | 6009 |
Chrnb4 | 5457 |
Chrnb2 | 4195 |
Chrnb3 | 2106 |
Chrna2 | 1054 |
Chrna7 | 1 |
Chrna1 | -542 |
PROLONGED ERK ACTIVATION EVENTS
747 | |
---|---|
set | PROLONGED ERK ACTIVATION EVENTS |
setSize | 14 |
pANOVA | 0.00938 |
s.dist | 0.401 |
p.adjustANOVA | 0.0582 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mapk1 | 8052 |
Map2k1 | 7865 |
Crkl | 7397 |
Ntrk1 | 6899 |
Crk | 6793 |
Ngf | 5435 |
Mapk3 | 5188 |
Rap1a | 5148 |
Frs2 | 3800 |
Rapgef1 | 3784 |
Ywhab | 3617 |
Braf | 1445 |
Kidins220 | -3045 |
Map2k2 | -4884 |
GeneID | Gene Rank |
---|---|
Mapk1 | 8052 |
Map2k1 | 7865 |
Crkl | 7397 |
Ntrk1 | 6899 |
Crk | 6793 |
Ngf | 5435 |
Mapk3 | 5188 |
Rap1a | 5148 |
Frs2 | 3800 |
Rapgef1 | 3784 |
Ywhab | 3617 |
Braf | 1445 |
Kidins220 | -3045 |
Map2k2 | -4884 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE
1045 | |
---|---|
set | SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE |
setSize | 15 |
pANOVA | 0.00762 |
s.dist | 0.398 |
p.adjustANOVA | 0.0504 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fig4 | 9255 |
Sacm1l | 7742 |
Pi4k2a | 7273 |
Pik3c3 | 6958 |
Pik3c2a | 6871 |
Pik3r4 | 6218 |
Ocrl | 6104 |
Vac14 | 5945 |
Pi4kb | 5175 |
Arf1 | 4881 |
Pi4ka | 74 |
Inpp5e | 44 |
Pikfyve | -1363 |
Arf3 | -1726 |
Pi4k2b | -2260 |
GeneID | Gene Rank |
---|---|
Fig4 | 9255 |
Sacm1l | 7742 |
Pi4k2a | 7273 |
Pik3c3 | 6958 |
Pik3c2a | 6871 |
Pik3r4 | 6218 |
Ocrl | 6104 |
Vac14 | 5945 |
Pi4kb | 5175 |
Arf1 | 4881 |
Pi4ka | 74 |
Inpp5e | 44 |
Pikfyve | -1363 |
Arf3 | -1726 |
Pi4k2b | -2260 |
FERTILIZATION
321 | |
---|---|
set | FERTILIZATION |
setSize | 13 |
pANOVA | 0.013 |
s.dist | -0.398 |
p.adjustANOVA | 0.0727 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Acr | -7105 |
Ovgp1 | -6722 |
Catsperd | -6267 |
Adam21 | -5799 |
Catsper3 | -5156 |
Catsperg1 | -4963 |
Hvcn1 | -3776 |
B4galt1 | -2665 |
Izumo4 | -2140 |
Catsper2 | -1857 |
Kcnu1 | -1465 |
Cd9 | 3074 |
Catsperg2 | 6686 |
GeneID | Gene Rank |
---|---|
Acr | -7105 |
Ovgp1 | -6722 |
Catsperd | -6267 |
Adam21 | -5799 |
Catsper3 | -5156 |
Catsperg1 | -4963 |
Hvcn1 | -3776 |
B4galt1 | -2665 |
Izumo4 | -2140 |
Catsper2 | -1857 |
Kcnu1 | -1465 |
Cd9 | 3074 |
Catsperg2 | 6686 |
GLYCOSPHINGOLIPID METABOLISM
395 | |
---|---|
set | GLYCOSPHINGOLIPID METABOLISM |
setSize | 38 |
pANOVA | 2.63e-05 |
s.dist | 0.394 |
p.adjustANOVA | 0.000796 |
Top enriched genes
GeneID | Gene Rank |
---|---|
B3galnt1 | 9230 |
Gla | 9201 |
Arsa | 8981 |
Neu3 | 8944 |
Galc | 8882 |
Asah1 | 8647 |
Neu4 | 8522 |
Esyt1 | 8442 |
Arsb | 8276 |
B4galnt1 | 7463 |
Gba2 | 7449 |
Ugt8a | 6366 |
Psap | 6328 |
Ugcg | 6318 |
Gltp | 6022 |
Neu1 | 5420 |
Cerk | 5234 |
Neu2 | 5146 |
Cptp | 5086 |
Gm2a | 5036 |
GeneID | Gene Rank |
---|---|
B3galnt1 | 9230 |
Gla | 9201 |
Arsa | 8981 |
Neu3 | 8944 |
Galc | 8882 |
Asah1 | 8647 |
Neu4 | 8522 |
Esyt1 | 8442 |
Arsb | 8276 |
B4galnt1 | 7463 |
Gba2 | 7449 |
Ugt8a | 6366 |
Psap | 6328 |
Ugcg | 6318 |
Gltp | 6022 |
Neu1 | 5420 |
Cerk | 5234 |
Neu2 | 5146 |
Cptp | 5086 |
Gm2a | 5036 |
Hexb | 4729 |
Glb1l | 4482 |
Gba | 4021 |
Arsg | 3793 |
Arsk | 3006 |
Smpd1 | 2483 |
Smpd3 | 2172 |
Glb1 | 1254 |
Esyt2 | 802 |
Sumf1 | 674 |
Sumf2 | -146 |
Smpd2 | -414 |
Hexa | -484 |
Asah2 | -759 |
Ctsa | -3076 |
Arsj | -3299 |
Smpd4 | -3359 |
Esyt3 | -7344 |
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI
1037 | |
---|---|
set | SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI |
setSize | 18 |
pANOVA | 0.00383 |
s.dist | 0.394 |
p.adjustANOVA | 0.0307 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pigw | 9250 |
Pigf | 8812 |
Pigv | 8682 |
Piga | 8636 |
Pigx | 8506 |
Pigq | 6606 |
Pign | 6041 |
Pigg | 5972 |
Pigc | 5803 |
Pigm | 5616 |
Pigz | 4578 |
Pigo | 2824 |
Pigl | 1731 |
Dpm2 | 768 |
Pigh | -1609 |
Pigp | -1967 |
Pigyl | -2299 |
Pigb | -5198 |
GeneID | Gene Rank |
---|---|
Pigw | 9250 |
Pigf | 8812 |
Pigv | 8682 |
Piga | 8636 |
Pigx | 8506 |
Pigq | 6606 |
Pign | 6041 |
Pigg | 5972 |
Pigc | 5803 |
Pigm | 5616 |
Pigz | 4578 |
Pigo | 2824 |
Pigl | 1731 |
Dpm2 | 768 |
Pigh | -1609 |
Pigp | -1967 |
Pigyl | -2299 |
Pigb | -5198 |
SPHINGOLIPID METABOLISM
1008 | |
---|---|
set | SPHINGOLIPID METABOLISM |
setSize | 80 |
pANOVA | 1.27e-09 |
s.dist | 0.393 |
p.adjustANOVA | 1.87e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ormdl1 | 9234 |
B3galnt1 | 9230 |
Gla | 9201 |
Arsa | 8981 |
Neu3 | 8944 |
Galc | 8882 |
Sptlc1 | 8849 |
Asah1 | 8647 |
Neu4 | 8522 |
Esyt1 | 8442 |
Arsb | 8276 |
Fa2h | 8124 |
Plpp3 | 7944 |
Degs1 | 7942 |
Ormdl2 | 7928 |
Sgms1 | 7852 |
B4galnt1 | 7463 |
Gba2 | 7449 |
Degs2 | 7360 |
Sptssa | 7264 |
GeneID | Gene Rank |
---|---|
Ormdl1 | 9234 |
B3galnt1 | 9230 |
Gla | 9201 |
Arsa | 8981 |
Neu3 | 8944 |
Galc | 8882 |
Sptlc1 | 8849 |
Asah1 | 8647 |
Neu4 | 8522 |
Esyt1 | 8442 |
Arsb | 8276 |
Fa2h | 8124 |
Plpp3 | 7944 |
Degs1 | 7942 |
Ormdl2 | 7928 |
Sgms1 | 7852 |
B4galnt1 | 7463 |
Gba2 | 7449 |
Degs2 | 7360 |
Sptssa | 7264 |
Osbp | 7103 |
Prkd1 | 7026 |
Plpp1 | 6837 |
Aldh3a2 | 6664 |
Ugt8a | 6366 |
Psap | 6328 |
Ugcg | 6318 |
Prkd3 | 6316 |
Sgms2 | 6026 |
Cert1 | 6023 |
Gltp | 6022 |
Cers5 | 5942 |
Cers1 | 5877 |
Sgpp1 | 5776 |
Csnk1g2 | 5732 |
Sgpp2 | 5582 |
Neu1 | 5420 |
Cerk | 5234 |
Neu2 | 5146 |
Sgpl1 | 5129 |
Cptp | 5086 |
Gm2a | 5036 |
Ormdl3 | 4973 |
Sphk1 | 4789 |
Hexb | 4729 |
Sptlc2 | 4652 |
Glb1l | 4482 |
Cers6 | 4399 |
Sptlc3 | 4198 |
Vapb | 4056 |
Gba | 4021 |
Arsg | 3793 |
Ppm1l | 3788 |
Sptssb | 3143 |
Cers2 | 3111 |
Arsk | 3006 |
Prkd2 | 2917 |
Smpd1 | 2483 |
Spns2 | 2458 |
Smpd3 | 2172 |
Plpp2 | 1347 |
Glb1 | 1254 |
Esyt2 | 802 |
Sumf1 | 674 |
Sumf2 | -146 |
Smpd2 | -414 |
Hexa | -484 |
Asah2 | -759 |
Acer2 | -1956 |
Sphk2 | -2021 |
Vapa | -2539 |
Kdsr | -2813 |
Aldh3b1 | -2904 |
Ctsa | -3076 |
Acer3 | -3257 |
Arsj | -3299 |
Smpd4 | -3359 |
Samd8 | -5797 |
Cers4 | -7033 |
Esyt3 | -7344 |
DEFECTS OF CONTACT ACTIVATION SYSTEM CAS AND KALLIKREIN KININ SYSTEM KKS
221 | |
---|---|
set | DEFECTS OF CONTACT ACTIVATION SYSTEM CAS AND KALLIKREIN KININ SYSTEM KKS |
setSize | 11 |
pANOVA | 0.0242 |
s.dist | -0.392 |
p.adjustANOVA | 0.107 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gp1ba | -8198 |
Gp1bb | -8001 |
Ggcx | -6806 |
Tpst1 | -5527 |
Serping1 | -5474 |
Klkb1 | -4297 |
F12 | -2627 |
F8 | -2132 |
Gp5 | -310 |
Vwf | 3862 |
Tpst2 | 7745 |
GeneID | Gene Rank |
---|---|
Gp1ba | -8198 |
Gp1bb | -8001 |
Ggcx | -6806 |
Tpst1 | -5527 |
Serping1 | -5474 |
Klkb1 | -4297 |
F12 | -2627 |
F8 | -2132 |
Gp5 | -310 |
Vwf | 3862 |
Tpst2 | 7745 |
SPHINGOLIPID DE NOVO BIOSYNTHESIS
1007 | |
---|---|
set | SPHINGOLIPID DE NOVO BIOSYNTHESIS |
setSize | 42 |
pANOVA | 1.25e-05 |
s.dist | 0.39 |
p.adjustANOVA | 0.000522 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ormdl1 | 9234 |
Sptlc1 | 8849 |
Fa2h | 8124 |
Plpp3 | 7944 |
Degs1 | 7942 |
Ormdl2 | 7928 |
Sgms1 | 7852 |
Degs2 | 7360 |
Sptssa | 7264 |
Osbp | 7103 |
Prkd1 | 7026 |
Plpp1 | 6837 |
Aldh3a2 | 6664 |
Prkd3 | 6316 |
Sgms2 | 6026 |
Cert1 | 6023 |
Cers5 | 5942 |
Cers1 | 5877 |
Sgpp1 | 5776 |
Csnk1g2 | 5732 |
GeneID | Gene Rank |
---|---|
Ormdl1 | 9234 |
Sptlc1 | 8849 |
Fa2h | 8124 |
Plpp3 | 7944 |
Degs1 | 7942 |
Ormdl2 | 7928 |
Sgms1 | 7852 |
Degs2 | 7360 |
Sptssa | 7264 |
Osbp | 7103 |
Prkd1 | 7026 |
Plpp1 | 6837 |
Aldh3a2 | 6664 |
Prkd3 | 6316 |
Sgms2 | 6026 |
Cert1 | 6023 |
Cers5 | 5942 |
Cers1 | 5877 |
Sgpp1 | 5776 |
Csnk1g2 | 5732 |
Sgpp2 | 5582 |
Sgpl1 | 5129 |
Ormdl3 | 4973 |
Sphk1 | 4789 |
Sptlc2 | 4652 |
Cers6 | 4399 |
Sptlc3 | 4198 |
Vapb | 4056 |
Ppm1l | 3788 |
Sptssb | 3143 |
Cers2 | 3111 |
Prkd2 | 2917 |
Spns2 | 2458 |
Plpp2 | 1347 |
Acer2 | -1956 |
Sphk2 | -2021 |
Vapa | -2539 |
Kdsr | -2813 |
Aldh3b1 | -2904 |
Acer3 | -3257 |
Samd8 | -5797 |
Cers4 | -7033 |
NUCLEOBASE BIOSYNTHESIS
654 | |
---|---|
set | NUCLEOBASE BIOSYNTHESIS |
setSize | 15 |
pANOVA | 0.01 |
s.dist | 0.384 |
p.adjustANOVA | 0.061 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Paics | 9163 |
Atic | 7987 |
Adsl | 7826 |
Gart | 7723 |
Adss | 6791 |
Impdh2 | 6200 |
Ppat | 5022 |
Umps | 4176 |
Impdh1 | 3875 |
Gmps | 3087 |
Lhpp | 2720 |
Adssl1 | 2686 |
Dhodh | 140 |
Cad | -3152 |
Pfas | -4910 |
GeneID | Gene Rank |
---|---|
Paics | 9163 |
Atic | 7987 |
Adsl | 7826 |
Gart | 7723 |
Adss | 6791 |
Impdh2 | 6200 |
Ppat | 5022 |
Umps | 4176 |
Impdh1 | 3875 |
Gmps | 3087 |
Lhpp | 2720 |
Adssl1 | 2686 |
Dhodh | 140 |
Cad | -3152 |
Pfas | -4910 |
COHESIN LOADING ONTO CHROMATIN
164 | |
---|---|
set | COHESIN LOADING ONTO CHROMATIN |
setSize | 10 |
pANOVA | 0.0374 |
s.dist | 0.38 |
p.adjustANOVA | 0.143 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rad21 | 8790 |
Stag2 | 8475 |
Pds5b | 8032 |
Stag1 | 7069 |
Mau2 | 3628 |
Smc1a | 3616 |
Pds5a | 3446 |
Wapl | 1482 |
Nipbl | 1043 |
Smc3 | -6346 |
GeneID | Gene Rank |
---|---|
Rad21 | 8790 |
Stag2 | 8475 |
Pds5b | 8032 |
Stag1 | 7069 |
Mau2 | 3628 |
Smc1a | 3616 |
Pds5a | 3446 |
Wapl | 1482 |
Nipbl | 1043 |
Smc3 | -6346 |
CTLA4 INHIBITORY SIGNALING
193 | |
---|---|
set | CTLA4 INHIBITORY SIGNALING |
setSize | 20 |
pANOVA | 0.00362 |
s.dist | 0.376 |
p.adjustANOVA | 0.0296 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ptpn11 | 9296 |
Yes1 | 8654 |
Fyn | 8650 |
Ppp2r5d | 8038 |
Ppp2r5c | 7442 |
Ppp2r5e | 7405 |
Ppp2r5b | 6724 |
Akt1 | 6662 |
Src | 5680 |
Ppp2ca | 5171 |
Ppp2r1a | 4643 |
Akt3 | 4257 |
Ppp2r1b | 3997 |
Lck | 1852 |
Ppp2r5a | 972 |
Cd86 | 361 |
Akt2 | -508 |
Ppp2cb | -1872 |
Lyn | -2069 |
Cd80 | -7687 |
GeneID | Gene Rank |
---|---|
Ptpn11 | 9296 |
Yes1 | 8654 |
Fyn | 8650 |
Ppp2r5d | 8038 |
Ppp2r5c | 7442 |
Ppp2r5e | 7405 |
Ppp2r5b | 6724 |
Akt1 | 6662 |
Src | 5680 |
Ppp2ca | 5171 |
Ppp2r1a | 4643 |
Akt3 | 4257 |
Ppp2r1b | 3997 |
Lck | 1852 |
Ppp2r5a | 972 |
Cd86 | 361 |
Akt2 | -508 |
Ppp2cb | -1872 |
Lyn | -2069 |
Cd80 | -7687 |
ADENYLATE CYCLASE INHIBITORY PATHWAY
37 | |
---|---|
set | ADENYLATE CYCLASE INHIBITORY PATHWAY |
setSize | 13 |
pANOVA | 0.0198 |
s.dist | 0.373 |
p.adjustANOVA | 0.0944 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gnai1 | 8119 |
Adcy8 | 7381 |
Gnai2 | 6928 |
Gnai3 | 6827 |
Adcy3 | 5592 |
Adcy5 | 5062 |
Gnal | 4031 |
Adcy1 | 3295 |
Adcy2 | 3030 |
Adcy9 | 1919 |
Adcy7 | 1718 |
Adcy4 | -1197 |
Adcy6 | -2493 |
GeneID | Gene Rank |
---|---|
Gnai1 | 8119 |
Adcy8 | 7381 |
Gnai2 | 6928 |
Gnai3 | 6827 |
Adcy3 | 5592 |
Adcy5 | 5062 |
Gnal | 4031 |
Adcy1 | 3295 |
Adcy2 | 3030 |
Adcy9 | 1919 |
Adcy7 | 1718 |
Adcy4 | -1197 |
Adcy6 | -2493 |
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND
744 | |
---|---|
set | PROCESSIVE SYNTHESIS ON THE LAGGING STRAND |
setSize | 15 |
pANOVA | 0.0124 |
s.dist | 0.373 |
p.adjustANOVA | 0.071 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Prim2 | 8549 |
Prim1 | 7456 |
Fen1 | 7372 |
Pola2 | 7148 |
Pcna | 7097 |
Rpa1 | 6737 |
Pola1 | 5712 |
Pold2 | 2951 |
Pold3 | 2918 |
Rpa2 | 2323 |
Rpa3 | 2109 |
Pold1 | 1587 |
Dna2 | 1476 |
Pold4 | -1605 |
Lig1 | -3924 |
GeneID | Gene Rank |
---|---|
Prim2 | 8549 |
Prim1 | 7456 |
Fen1 | 7372 |
Pola2 | 7148 |
Pcna | 7097 |
Rpa1 | 6737 |
Pola1 | 5712 |
Pold2 | 2951 |
Pold3 | 2918 |
Rpa2 | 2323 |
Rpa3 | 2109 |
Pold1 | 1587 |
Dna2 | 1476 |
Pold4 | -1605 |
Lig1 | -3924 |
RHOV GTPASE CYCLE
869 | |
---|---|
set | RHOV GTPASE CYCLE |
setSize | 33 |
pANOVA | 0.000241 |
s.dist | 0.369 |
p.adjustANOVA | 0.00389 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tpm4 | 9047 |
Git1 | 8959 |
Nck1 | 8828 |
Pak2 | 8711 |
Sh3rf1 | 7833 |
Wdr6 | 7605 |
Peak1 | 7447 |
Pak1 | 7413 |
Depdc1b | 6978 |
Arhgap12 | 6937 |
Sptan1 | 6656 |
Cltc | 6291 |
Wasl | 6063 |
Sptbn1 | 5623 |
Txnl1 | 5486 |
Pik3r1 | 5024 |
Usp9x | 4932 |
Epha2 | 4386 |
Arhgef7 | 4333 |
Cdc42 | 4309 |
GeneID | Gene Rank |
---|---|
Tpm4 | 9047 |
Git1 | 8959 |
Nck1 | 8828 |
Pak2 | 8711 |
Sh3rf1 | 7833 |
Wdr6 | 7605 |
Peak1 | 7447 |
Pak1 | 7413 |
Depdc1b | 6978 |
Arhgap12 | 6937 |
Sptan1 | 6656 |
Cltc | 6291 |
Wasl | 6063 |
Sptbn1 | 5623 |
Txnl1 | 5486 |
Pik3r1 | 5024 |
Usp9x | 4932 |
Epha2 | 4386 |
Arhgef7 | 4333 |
Cdc42 | 4309 |
Pak6 | 4038 |
Dlg5 | 2786 |
Tpm3 | 2377 |
Vangl1 | 1703 |
Rhov | 543 |
Iqgap1 | 25 |
Ccp110 | -28 |
Myo9a | -37 |
Dst | -927 |
Nck2 | -2459 |
Git2 | -3117 |
Zfp512b | -5052 |
Cep97 | -6532 |
PLATELET SENSITIZATION BY LDL
720 | |
---|---|
set | PLATELET SENSITIZATION BY LDL |
setSize | 15 |
pANOVA | 0.0138 |
s.dist | 0.367 |
p.adjustANOVA | 0.0745 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ptpn11 | 9296 |
Pla2g4a | 8646 |
Ppp2r5d | 8038 |
Ppp2r5c | 7442 |
Ppp2r5e | 7405 |
Ppp2r5b | 6724 |
Ppp2ca | 5171 |
Ppp2r1a | 4643 |
Ppp2r1b | 3997 |
Mapk14 | 1963 |
Ppp2r5a | 972 |
Lrp8 | 629 |
Ptpn6 | -278 |
Ppp2cb | -1872 |
Pecam1 | -5637 |
GeneID | Gene Rank |
---|---|
Ptpn11 | 9296 |
Pla2g4a | 8646 |
Ppp2r5d | 8038 |
Ppp2r5c | 7442 |
Ppp2r5e | 7405 |
Ppp2r5b | 6724 |
Ppp2ca | 5171 |
Ppp2r1a | 4643 |
Ppp2r1b | 3997 |
Mapk14 | 1963 |
Ppp2r5a | 972 |
Lrp8 | 629 |
Ptpn6 | -278 |
Ppp2cb | -1872 |
Pecam1 | -5637 |
INSULIN PROCESSING
456 | |
---|---|
set | INSULIN PROCESSING |
setSize | 24 |
pANOVA | 0.00196 |
s.dist | 0.365 |
p.adjustANOVA | 0.0188 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pcsk1 | 9031 |
Myrip | 8778 |
Exoc5 | 8427 |
Ero1a | 8332 |
Exoc7 | 8318 |
Exoc3 | 8205 |
Slc30a7 | 6963 |
Slc30a5 | 6863 |
Pcsk2 | 6800 |
Cpe | 6309 |
Myo5a | 5840 |
Kif5a | 5703 |
Exoc1 | 4048 |
Kif5c | 3833 |
Exoc4 | 2467 |
Exoc2 | 1208 |
Exoc8 | 1072 |
Ero1b | 927 |
Exoc6 | 86 |
Rab27a | -33 |
GeneID | Gene Rank |
---|---|
Pcsk1 | 9031 |
Myrip | 8778 |
Exoc5 | 8427 |
Ero1a | 8332 |
Exoc7 | 8318 |
Exoc3 | 8205 |
Slc30a7 | 6963 |
Slc30a5 | 6863 |
Pcsk2 | 6800 |
Cpe | 6309 |
Myo5a | 5840 |
Kif5a | 5703 |
Exoc1 | 4048 |
Kif5c | 3833 |
Exoc4 | 2467 |
Exoc2 | 1208 |
Exoc8 | 1072 |
Ero1b | 927 |
Exoc6 | 86 |
Rab27a | -33 |
Slc30a6 | -372 |
Kif5b | -2113 |
Stx1a | -4257 |
Vamp2 | -5509 |
LDL CLEARANCE
516 | |
---|---|
set | LDL CLEARANCE |
setSize | 16 |
pANOVA | 0.0115 |
s.dist | 0.365 |
p.adjustANOVA | 0.0671 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Soat1 | 8895 |
Lipa | 7988 |
Nceh1 | 7697 |
Ap2b1 | 7444 |
Ap2a2 | 7134 |
Npc1 | 6395 |
Cltc | 6291 |
Ldlrap1 | 4884 |
Ap2m1 | 4122 |
Ap2a1 | 3883 |
Lsr | 3285 |
Clta | -54 |
Npc2 | -185 |
Ldlr | -1174 |
Pcsk9 | -1699 |
Ap2s1 | -4313 |
GeneID | Gene Rank |
---|---|
Soat1 | 8895 |
Lipa | 7988 |
Nceh1 | 7697 |
Ap2b1 | 7444 |
Ap2a2 | 7134 |
Npc1 | 6395 |
Cltc | 6291 |
Ldlrap1 | 4884 |
Ap2m1 | 4122 |
Ap2a1 | 3883 |
Lsr | 3285 |
Clta | -54 |
Npc2 | -185 |
Ldlr | -1174 |
Pcsk9 | -1699 |
Ap2s1 | -4313 |
FATTY ACYL COA BIOSYNTHESIS
314 | |
---|---|
set | FATTY ACYL COA BIOSYNTHESIS |
setSize | 32 |
pANOVA | 0.000406 |
s.dist | 0.361 |
p.adjustANOVA | 0.00569 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Acsbg1 | 9232 |
Ppt1 | 9171 |
Rpp14 | 9016 |
Acsl3 | 8989 |
Elovl2 | 8860 |
Acsl6 | 8499 |
Hsd17b12 | 7925 |
Acsl1 | 7586 |
Acsl4 | 7378 |
Hacd2 | 7234 |
Hacd4 | 6744 |
Elovl4 | 6612 |
Elovl1 | 6340 |
Elovl5 | 6153 |
Cbr4 | 6113 |
Scd2 | 4934 |
Acly | 4805 |
Fasn | 4777 |
Scd1 | 4689 |
Acsf3 | 4043 |
GeneID | Gene Rank |
---|---|
Acsbg1 | 9232 |
Ppt1 | 9171 |
Rpp14 | 9016 |
Acsl3 | 8989 |
Elovl2 | 8860 |
Acsl6 | 8499 |
Hsd17b12 | 7925 |
Acsl1 | 7586 |
Acsl4 | 7378 |
Hacd2 | 7234 |
Hacd4 | 6744 |
Elovl4 | 6612 |
Elovl1 | 6340 |
Elovl5 | 6153 |
Cbr4 | 6113 |
Scd2 | 4934 |
Acly | 4805 |
Fasn | 4777 |
Scd1 | 4689 |
Acsf3 | 4043 |
Acsl5 | 3751 |
Elovl6 | 3694 |
Acaca | 3651 |
Hacd3 | 1138 |
Slc25a1 | -653 |
Ppt2 | -1275 |
Slc27a3 | -2394 |
Tecr | -4047 |
Morc2a | -4952 |
Hacd1 | -5403 |
Elovl7 | -5881 |
H2-Ke6 | -6646 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL
1049 | |
---|---|
set | SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL |
setSize | 10 |
pANOVA | 0.0493 |
s.dist | 0.359 |
p.adjustANOVA | 0.173 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Itpk1 | 9115 |
Nudt4 | 6774 |
Ppip5k2 | 6500 |
Ip6k1 | 6235 |
Ip6k3 | 5549 |
Ppip5k1 | 4291 |
Nudt11 | 4005 |
Nudt3 | 91 |
Ippk | -2232 |
Nudt10 | -2948 |
GeneID | Gene Rank |
---|---|
Itpk1 | 9115 |
Nudt4 | 6774 |
Ppip5k2 | 6500 |
Ip6k1 | 6235 |
Ip6k3 | 5549 |
Ppip5k1 | 4291 |
Nudt11 | 4005 |
Nudt3 | 91 |
Ippk | -2232 |
Nudt10 | -2948 |
RECEPTOR MEDIATED MITOPHAGY
777 | |
---|---|
set | RECEPTOR MEDIATED MITOPHAGY |
setSize | 11 |
pANOVA | 0.0406 |
s.dist | 0.357 |
p.adjustANOVA | 0.152 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fundc1 | 8456 |
Atg5 | 7623 |
Atg12 | 7486 |
Pgam5 | 7265 |
Src | 5680 |
Csnk2b | 3202 |
Map1lc3b | 2839 |
Ulk1 | 2740 |
Csnk2a1 | -320 |
Csnk2a2 | -490 |
Map1lc3a | -3610 |
GeneID | Gene Rank |
---|---|
Fundc1 | 8456 |
Atg5 | 7623 |
Atg12 | 7486 |
Pgam5 | 7265 |
Src | 5680 |
Csnk2b | 3202 |
Map1lc3b | 2839 |
Ulk1 | 2740 |
Csnk2a1 | -320 |
Csnk2a2 | -490 |
Map1lc3a | -3610 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX
814 | |
---|---|
set | REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX |
setSize | 15 |
pANOVA | 0.017 |
s.dist | 0.356 |
p.adjustANOVA | 0.0853 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Dld | 8678 |
Pdk3 | 8528 |
Pdha1 | 8186 |
Pdp1 | 8170 |
Rxra | 7494 |
Pdhx | 6298 |
Pdk2 | 6007 |
Pdhb | 5209 |
Pdpr | 4573 |
Ppard | 2869 |
Pdk4 | 2120 |
Dlat | -619 |
Gstz1 | -3089 |
Pdk1 | -4308 |
Pdp2 | -4491 |
GeneID | Gene Rank |
---|---|
Dld | 8678 |
Pdk3 | 8528 |
Pdha1 | 8186 |
Pdp1 | 8170 |
Rxra | 7494 |
Pdhx | 6298 |
Pdk2 | 6007 |
Pdhb | 5209 |
Pdpr | 4573 |
Ppard | 2869 |
Pdk4 | 2120 |
Dlat | -619 |
Gstz1 | -3089 |
Pdk1 | -4308 |
Pdp2 | -4491 |
INTRA GOLGI TRAFFIC
486 | |
---|---|
set | INTRA GOLGI TRAFFIC |
setSize | 43 |
pANOVA | 6.28e-05 |
s.dist | 0.353 |
p.adjustANOVA | 0.00145 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cog6 | 8754 |
Stx6 | 8556 |
Cux1 | 8537 |
Man1a | 8443 |
Rab6a | 8292 |
Cog1 | 7895 |
Snap29 | 7684 |
Cog4 | 7680 |
Vps45 | 7604 |
Vti1a | 7461 |
Man2a1 | 6911 |
Cog2 | 6693 |
Napb | 6585 |
Nsf | 6550 |
Napa | 6289 |
Napg | 6084 |
Man1a2 | 5666 |
Ric1 | 5576 |
Rab30 | 5442 |
Golim4 | 5329 |
GeneID | Gene Rank |
---|---|
Cog6 | 8754 |
Stx6 | 8556 |
Cux1 | 8537 |
Man1a | 8443 |
Rab6a | 8292 |
Cog1 | 7895 |
Snap29 | 7684 |
Cog4 | 7680 |
Vps45 | 7604 |
Vti1a | 7461 |
Man2a1 | 6911 |
Cog2 | 6693 |
Napb | 6585 |
Nsf | 6550 |
Napa | 6289 |
Napg | 6084 |
Man1a2 | 5666 |
Ric1 | 5576 |
Rab30 | 5442 |
Golim4 | 5329 |
Arf1 | 4881 |
Golga5 | 4558 |
Cog5 | 4246 |
Cyth3 | 4231 |
Cog3 | 3938 |
Gosr2 | 3125 |
Rab33b | 2428 |
Stx5a | 2302 |
Ykt6 | 2265 |
Man2a2 | 2234 |
Gosr1 | 2163 |
Rgp1 | 1998 |
Cog8 | 1608 |
Trip11 | 1607 |
Rab39 | 1406 |
Cyth1 | 447 |
Man1c1 | 264 |
Cog7 | -2694 |
Stx16 | -3185 |
Cyth2 | -3562 |
Rab36 | -4132 |
Bet1l | -6282 |
Cyth4 | -7803 |
RHOF GTPASE CYCLE
863 | |
---|---|
set | RHOF GTPASE CYCLE |
setSize | 41 |
pANOVA | 9.74e-05 |
s.dist | 0.352 |
p.adjustANOVA | 0.00205 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Farp1 | 9236 |
Snap23 | 9078 |
Tor1aip1 | 9062 |
Baiap2l1 | 8815 |
Esyt1 | 8442 |
Rhof | 8157 |
Add3 | 8016 |
Sowahc | 7962 |
Diaph1 | 7686 |
Cav1 | 7322 |
Depdc1b | 6978 |
Arhgap32 | 6944 |
Arhgap12 | 6937 |
Tmpo | 6444 |
Arhgap21 | 5835 |
Steap3 | 5651 |
Pik3r1 | 5024 |
Arhgap1 | 4996 |
Arhgap39 | 4865 |
Pik3r2 | 4622 |
GeneID | Gene Rank |
---|---|
Farp1 | 9236 |
Snap23 | 9078 |
Tor1aip1 | 9062 |
Baiap2l1 | 8815 |
Esyt1 | 8442 |
Rhof | 8157 |
Add3 | 8016 |
Sowahc | 7962 |
Diaph1 | 7686 |
Cav1 | 7322 |
Depdc1b | 6978 |
Arhgap32 | 6944 |
Arhgap12 | 6937 |
Tmpo | 6444 |
Arhgap21 | 5835 |
Steap3 | 5651 |
Pik3r1 | 5024 |
Arhgap1 | 4996 |
Arhgap39 | 4865 |
Pik3r2 | 4622 |
Mtmr1 | 4448 |
Arhgap5 | 3725 |
Lmnb1 | 3654 |
Fam169a | 3591 |
Akap12 | 3187 |
Diaph2 | 2912 |
Capzb | 2842 |
Diaph3 | 1929 |
Vangl1 | 1703 |
Rab7 | 1273 |
Actn1 | 1213 |
Srgap2 | 1106 |
Syde1 | -22 |
Basp1 | -724 |
Slc4a7 | -912 |
Mcam | -1153 |
Baiap2l2 | -2596 |
Myo9b | -3015 |
Vamp3 | -3112 |
Senp1 | -3882 |
Actb | -7868 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES
755 | |
---|---|
set | PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES |
setSize | 14 |
pANOVA | 0.0238 |
s.dist | 0.349 |
p.adjustANOVA | 0.107 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Elmo1 | 8839 |
Rac1 | 8591 |
Rasa1 | 8289 |
Crk | 6793 |
Arhgap35 | 6277 |
Ptk6 | 5618 |
Bcar1 | 4183 |
Kras | 3745 |
Elmo2 | 3368 |
Dock1 | 2201 |
Rhoa | 2051 |
Pxn | -949 |
Hras | -3603 |
Nras | -4341 |
GeneID | Gene Rank |
---|---|
Elmo1 | 8839 |
Rac1 | 8591 |
Rasa1 | 8289 |
Crk | 6793 |
Arhgap35 | 6277 |
Ptk6 | 5618 |
Bcar1 | 4183 |
Kras | 3745 |
Elmo2 | 3368 |
Dock1 | 2201 |
Rhoa | 2051 |
Pxn | -949 |
Hras | -3603 |
Nras | -4341 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS
658 | |
---|---|
set | NUCLEOTIDE LIKE PURINERGIC RECEPTORS |
setSize | 13 |
pANOVA | 0.0301 |
s.dist | 0.347 |
p.adjustANOVA | 0.122 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gpr17 | 9197 |
P2ry1 | 9156 |
Adora1 | 8007 |
P2ry13 | 7043 |
Adora2a | 5291 |
Lpar4 | 4674 |
Adora2b | 3472 |
P2ry12 | 2821 |
P2ry6 | 2631 |
P2ry14 | 68 |
Lpar6 | 33 |
Adora3 | -1046 |
P2ry2 | -4090 |
GeneID | Gene Rank |
---|---|
Gpr17 | 9197 |
P2ry1 | 9156 |
Adora1 | 8007 |
P2ry13 | 7043 |
Adora2a | 5291 |
Lpar4 | 4674 |
Adora2b | 3472 |
P2ry12 | 2821 |
P2ry6 | 2631 |
P2ry14 | 68 |
Lpar6 | 33 |
Adora3 | -1046 |
P2ry2 | -4090 |
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE
116 | |
---|---|
set | CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE |
setSize | 49 |
pANOVA | 2.94e-05 |
s.dist | 0.345 |
p.adjustANOVA | 0.000865 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rp2 | 9161 |
Lztfl1 | 8991 |
Exoc5 | 8427 |
Exoc7 | 8318 |
Exoc3 | 8205 |
Tcp1 | 8148 |
Unc119b | 8116 |
Arf4 | 7436 |
Mchr1 | 7425 |
Arl6 | 7411 |
Mkks | 7250 |
Bbs1 | 7110 |
Rab3ip | 7096 |
Cct3 | 6618 |
Bbs7 | 6425 |
Rab11fip3 | 6241 |
Pde6d | 6158 |
Cct5 | 6045 |
Gbf1 | 5754 |
Ttc8 | 5746 |
GeneID | Gene Rank |
---|---|
Rp2 | 9161 |
Lztfl1 | 8991 |
Exoc5 | 8427 |
Exoc7 | 8318 |
Exoc3 | 8205 |
Tcp1 | 8148 |
Unc119b | 8116 |
Arf4 | 7436 |
Mchr1 | 7425 |
Arl6 | 7411 |
Mkks | 7250 |
Bbs1 | 7110 |
Rab3ip | 7096 |
Cct3 | 6618 |
Bbs7 | 6425 |
Rab11fip3 | 6241 |
Pde6d | 6158 |
Cct5 | 6045 |
Gbf1 | 5754 |
Ttc8 | 5746 |
Bbs10 | 5621 |
Bbs4 | 5540 |
Cct4 | 5520 |
Smo | 5122 |
Cys1 | 4281 |
Rab11a | 4161 |
Exoc1 | 4048 |
Cct2 | 3787 |
Sstr3 | 3325 |
Cct8 | 3153 |
Rab8a | 2930 |
Arl13b | 2806 |
Exoc4 | 2467 |
Exoc2 | 1208 |
Exoc8 | 1072 |
Bbs2 | 306 |
Exoc6 | 86 |
Inpp5e | 44 |
Asap1 | 21 |
Bbs12 | -115 |
Pkd2 | -195 |
Bbs9 | -196 |
Bbip1 | -690 |
Cnga4 | -1815 |
Arl3 | -2282 |
Pkd1 | -2879 |
Nphp3 | -3678 |
Bbs5 | -4881 |
Cngb1 | -8095 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.3.1 (2023-06-16)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.3 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so; LAPACK version 3.10.0
##
## locale:
## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8
## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8
## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C
##
## time zone: /usr/share/zoneinfo/Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] GGally_2.1.2 gtools_3.9.4
## [3] echarts4r_0.4.5 beeswarm_0.4.0
## [5] pkgload_1.3.2.1 vioplot_0.4.0
## [7] sm_2.2-5.7.1 kableExtra_1.3.4
## [9] topconfects_1.16.0 limma_3.56.2
## [11] eulerr_7.0.0 mitch_1.12.0
## [13] MASS_7.3-60 fgsea_1.26.0
## [15] gplots_3.1.3 DESeq2_1.40.2
## [17] SummarizedExperiment_1.30.2 Biobase_2.60.0
## [19] MatrixGenerics_1.12.3 matrixStats_1.0.0
## [21] GenomicRanges_1.52.0 GenomeInfoDb_1.36.2
## [23] IRanges_2.34.1 S4Vectors_0.38.1
## [25] BiocGenerics_0.46.0 reshape2_1.4.4
## [27] lubridate_1.9.2 forcats_1.0.0
## [29] stringr_1.5.0 dplyr_1.1.2
## [31] purrr_1.0.2 readr_2.1.4
## [33] tidyr_1.3.0 tibble_3.2.1
## [35] ggplot2_3.4.3 tidyverse_2.0.0
## [37] zoo_1.8-12
##
## loaded via a namespace (and not attached):
## [1] bitops_1.0-7 gridExtra_2.3 rlang_1.1.1
## [4] magrittr_2.0.3 compiler_4.3.1 polylabelr_0.2.0
## [7] systemfonts_1.0.4 vctrs_0.6.3 rvest_1.0.3
## [10] pkgconfig_2.0.3 crayon_1.5.2 fastmap_1.1.1
## [13] XVector_0.40.0 ellipsis_0.3.2 labeling_0.4.2
## [16] caTools_1.18.2 utf8_1.2.3 promises_1.2.1
## [19] rmarkdown_2.24 tzdb_0.4.0 xfun_0.40
## [22] zlibbioc_1.46.0 cachem_1.0.8 jsonlite_1.8.7
## [25] highr_0.10 later_1.3.1 DelayedArray_0.26.7
## [28] reshape_0.8.9 BiocParallel_1.34.2 parallel_4.3.1
## [31] R6_2.5.1 bslib_0.5.1 stringi_1.7.12
## [34] RColorBrewer_1.1-3 jquerylib_0.1.4 assertthat_0.2.1
## [37] Rcpp_1.0.11 knitr_1.43 httpuv_1.6.11
## [40] Matrix_1.6-1 timechange_0.2.0 tidyselect_1.2.0
## [43] rstudioapi_0.15.0 abind_1.4-5 yaml_2.3.7
## [46] codetools_0.2-19 lattice_0.21-8 plyr_1.8.8
## [49] shiny_1.7.5 withr_2.5.0 evaluate_0.21
## [52] polyclip_1.10-4 xml2_1.3.5 pillar_1.9.0
## [55] KernSmooth_2.23-22 generics_0.1.3 RCurl_1.98-1.12
## [58] hms_1.1.3 munsell_0.5.0 scales_1.2.1
## [61] xtable_1.8-4 glue_1.6.2 tools_4.3.1
## [64] data.table_1.14.8 webshot_0.5.5 locfit_1.5-9.8
## [67] fastmatch_1.1-4 cowplot_1.1.1 grid_4.3.1
## [70] colorspace_2.1-0 GenomeInfoDbData_1.2.10 cli_3.6.1
## [73] fansi_1.0.4 viridisLite_0.4.2 S4Arrays_1.0.5
## [76] svglite_2.1.1 gtable_0.3.4 sass_0.4.7
## [79] digest_0.6.33 farver_2.1.1 htmlwidgets_1.6.2
## [82] htmltools_0.5.6 lifecycle_1.0.3 httr_1.4.7
## [85] mime_0.12
END of report